Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,8065,80,1.64 [0.47-5.68],0.4373596037242827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,7871,79,0.85 [0.56-1.28],0.4359817775569394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,9137,86,0.86 [0.61-1.22],0.4020187636483019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,7802,75,0.86 [0.46-1.63],0.651792083242844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,9082,87,0.98 [0.71-1.37],0.9275765637229312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,9137,86,0.92 [0.69-1.24],0.600261209724822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,8052,80,1.16 [1.00-1.34],0.0511214950162249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,7802,75,0.78 [0.55-1.11],0.1688242881616743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",8972,86,1.12 [0.89-1.41],0.3261439139810163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",7921,80,0.59 [0.38-0.93],0.0228348951227553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",8046,81,1.09 [0.86-1.37],0.4925033600902047
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,9084,87,0.91 [0.45-1.82],0.7848399683036127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,8052,80,0.90 [0.41-2.01],0.8057017373684767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,8996,83,1.17 [0.82-1.68],0.3943559703311783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,7902,78,0.69 [0.35-1.39],0.3048147510146836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,8011,80,0.95 [0.78-1.15],0.5751063909836062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,9173,88,0.82 [0.55-1.22],0.3257462027161301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,7830,79,0.94 [0.57-1.54],0.8026200417493193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,9234,86,1.13 [0.62-2.06],0.6817179564635825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,9234,88,1.39 [1.01-1.92],0.044306171370745
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,8023,82,0.59 [0.32-1.09],0.0948886204482977
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,7830,79,0.55 [0.29-1.05],0.0681117574623614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,7802,75,0.93 [0.52-1.67],0.8200355841339818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",8996,83,1.00 [0.63-1.58],0.9911920657371186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,7802,75,1.00 [0.66-1.50],0.981418892411883
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,9008,86,0.69 [0.34-1.40],0.3011083270014648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,9096,87,1.07 [0.49-2.33],0.8737991906213048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,9173,88,0.87 [0.63-1.22],0.4276893485553231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,7802,75,0.81 [0.53-1.24],0.3405214765301072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,7868,78,1.07 [0.77-1.49],0.6920176010653508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,9266,87,1.27 [0.75-2.16],0.3786159798151048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,9135,85,1.15 [0.73-1.79],0.5530730210106858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,7830,79,1.36 [0.73-2.54],0.3323297902959011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,8996,83,1.09 [0.57-2.08],0.7902315746825557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,9110,87,1.71 [1.00-2.94],0.0520501106841221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,9266,87,1.27 [0.72-2.23],0.4105531002237805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,9225,88,1.78 [0.91-3.50],0.091725033287573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,8011,80,1.22 [0.60-2.48],0.5838249745613451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,7830,79,0.97 [0.47-1.99],0.9337341295913768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,9282,86,0.83 [0.36-1.92],0.6702353282940621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,9137,86,1.23 [0.78-1.95],0.3714597189187995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,8996,83,0.57 [0.26-1.21],0.1428687055903851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,7830,79,0.64 [0.34-1.24],0.1868018254085308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,9214,89,1.03 [0.67-1.57],0.9067462578069504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,8062,80,1.27 [0.66-2.47],0.4784556126349596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,7871,79,1.67 [0.65-4.29],0.286332176455243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,8046,81,1.04 [0.60-1.82],0.8886829996833697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,8972,86,1.01 [0.61-1.70],0.9561082943853366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,7902,78,1.14 [0.83-1.55],0.4210983601343864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,9096,87,1.13 [0.64-2.00],0.6737702266122988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,7902,78,0.83 [0.45-1.53],0.5437998422287078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,8011,80,0.99 [0.67-1.47],0.9735208758239836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,9220,88,0.75 [0.37-1.50],0.412858103494686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,9253,86,0.90 [0.46-1.74],0.7524838012158634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,8046,81,0.83 [0.40-1.70],0.6072487894604116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,9137,86,1.19 [0.92-1.55],0.1836379315043936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,9173,88,0.74 [0.37-1.50],0.4067840783203553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,7783,80,0.97 [0.71-1.33],0.8466228639605872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,7902,78,1.00 [0.75-1.35],0.979292068457273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,8996,83,1.08 [0.85-1.36],0.5239439634538079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,8065,80,0.90 [0.66-1.24],0.5281879020269582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,9252,88,1.96 [0.94-4.10],0.0725276471818383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,7802,75,0.82 [0.57-1.20],0.309183692085452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,7902,78,0.83 [0.63-1.09],0.1845939736794435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFM,Afamin,8065,80,1.38 [0.45-4.24],0.5728844868009673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,9084,87,0.87 [0.65-1.16],0.3358305615151121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,7783,80,0.99 [0.78-1.27],0.9677822774871327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,9157,88,1.45 [0.93-2.27],0.0989445834739435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,8870,81,0.85 [0.70-1.03],0.0955541304619674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,8951,86,0.86 [0.62-1.20],0.3823760596400881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,9220,88,1.29 [0.75-2.21],0.3575100130140822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,9266,87,1.50 [1.03-2.19],0.0342356989637428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,8052,80,1.49 [0.61-3.62],0.3768641968581226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,9173,88,1.04 [0.81-1.33],0.7872569566184906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,9173,88,1.07 [0.82-1.41],0.6057520352835564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,7871,79,1.02 [0.52-2.03],0.9463728383265584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,7871,79,1.84 [0.98-3.43],0.0568351204997438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,8023,82,1.03 [0.76-1.39],0.8707523740487515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,8052,80,0.96 [0.45-2.05],0.9127028208965158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,9168,88,0.96 [0.77-1.19],0.6944234727154388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",7841,81,0.94 [0.72-1.23],0.6671460571090659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,8972,86,0.96 [0.66-1.39],0.8250797080061268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,7871,79,1.33 [1.01-1.75],0.0417447600108963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",9122,86,1.08 [0.90-1.29],0.4096641672686908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,9173,88,0.95 [0.71-1.27],0.7366172497630068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",8042,80,0.99 [0.81-1.22],0.945623951671478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,7902,78,0.94 [0.33-2.66],0.912106938927151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,8972,86,1.05 [0.81-1.36],0.706759276902732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,7841,81,0.64 [0.43-0.97],0.034468321155236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,8996,83,1.19 [0.89-1.59],0.2333684846983673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,7830,79,0.92 [0.65-1.28],0.6142782178175404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,8948,82,1.03 [0.76-1.39],0.8416481308541885
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,8035,82,0.97 [0.82-1.15],0.715683315199714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,8931,86,0.95 [0.67-1.34],0.76867760994674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,9282,86,1.76 [0.65-4.71],0.2636504577727273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,9182,88,0.93 [0.65-1.32],0.6752931766763699
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",8023,82,1.10 [0.76-1.57],0.618724418287284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",9133,88,0.77 [0.55-1.08],0.1267830613260562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",8035,82,1.15 [0.75-1.77],0.5298183770978645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,7921,80,1.17 [0.79-1.71],0.4360896719753243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,7830,79,0.84 [0.69-1.01],0.057706289934068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",9137,86,1.22 [1.01-1.47],0.0363758826040049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,9008,86,1.21 [0.65-2.24],0.551802270587801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,9235,88,1.95 [0.78-4.88],0.151024153908458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,8062,80,1.69 [0.75-3.77],0.2024912434710722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,8948,82,0.90 [0.64-1.26],0.5373925404036183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,7841,81,1.07 [0.70-1.63],0.7626872381061436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,9137,86,0.80 [0.35-1.85],0.6018069308729578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,9008,86,1.02 [0.68-1.54],0.918689617063251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,7902,78,1.23 [0.71-2.14],0.4523034566291137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,7992,82,0.92 [0.58-1.46],0.7206936820746644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,8042,80,1.01 [0.76-1.35],0.9402578415586592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,7520,79,1.00 [0.65-1.53],0.9872672520093574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,8789,84,1.05 [0.69-1.58],0.8249662153559962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,8541,80,1.02 [0.67-1.56],0.913623381671314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,9168,85,0.86 [0.48-1.55],0.6196448133000247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,9139,88,0.93 [0.75-1.16],0.5367948277102865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,9252,88,0.95 [0.57-1.59],0.8453141014147125
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,9052,86,1.09 [0.56-2.12],0.8081012084963342
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,9190,87,1.18 [0.74-1.88],0.4886697936471579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,9186,85,0.92 [0.54-1.57],0.7586569595539463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,9202,88,1.40 [0.92-2.13],0.1204574740154472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,9252,88,1.06 [0.63-1.79],0.822901924012309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,7802,75,1.07 [0.81-1.41],0.6290410849636223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,7830,79,0.82 [0.62-1.08],0.1578895505688431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,7775,79,1.01 [0.69-1.47],0.973759663308592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,8972,86,0.91 [0.64-1.29],0.5862075106985338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,7871,79,0.99 [0.58-1.69],0.9736565866688692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,9214,85,1.11 [0.56-2.21],0.756320853913469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,7854,76,0.98 [0.59-1.63],0.9302555606501226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,8948,82,1.02 [0.81-1.28],0.8789825542888035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,9140,89,0.98 [0.74-1.29],0.8902421347925272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,7752,78,0.99 [0.72-1.34],0.9266048268427014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,9225,88,0.95 [0.72-1.25],0.7123333017562523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,9130,88,0.89 [0.68-1.17],0.4042613666284057
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,8926,82,0.80 [0.41-1.57],0.5168153821522465
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],9008,86,0.99 [0.72-1.37],0.9625436356734368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,9224,85,1.02 [0.54-1.94],0.943201270879086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,8023,82,1.00 [0.76-1.30],0.9897575481950288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,7841,81,0.95 [0.60-1.50],0.8254724353293683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,8011,80,0.98 [0.74-1.31],0.9166634084607864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,8042,80,0.90 [0.56-1.44],0.6626659730141471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,9137,86,1.01 [0.65-1.56],0.9667293143894214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,7983,78,1.01 [0.54-1.87],0.9832009625716234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,9219,88,0.94 [0.68-1.30],0.701248506742271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,9173,88,0.93 [0.65-1.34],0.6972473619365682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,8065,80,0.60 [0.25-1.47],0.2648301946332204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,8052,80,0.91 [0.59-1.41],0.6748628310295686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,8065,80,1.09 [0.61-1.92],0.7761800046564933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,8052,80,2.27 [0.92-5.60],0.0740886033130581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,7871,79,1.44 [0.84-2.47],0.1902945913531123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,8047,79,0.84 [0.44-1.60],0.5957750105925907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,7713,77,0.84 [0.46-1.52],0.5635268582329316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,8065,80,1.08 [0.82-1.41],0.5828754382986336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,8052,80,0.69 [0.40-1.19],0.1820248827819293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,9182,88,1.05 [0.63-1.78],0.8406348069090931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,8052,80,0.98 [0.70-1.39],0.9298266441788232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,9205,85,1.09 [0.53-2.23],0.8230534322354215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,9174,88,0.90 [0.67-1.19],0.4494822363054778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,7902,78,0.89 [0.74-1.09],0.2606047345355171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,9098,87,1.28 [0.85-1.94],0.2378260269142779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,7921,80,0.79 [0.56-1.12],0.1907210201961508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,9137,86,1.50 [1.01-2.21],0.044260501687136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,8011,80,0.92 [0.75-1.13],0.4258199647425175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,8035,82,0.96 [0.70-1.31],0.7933518228423204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,9134,87,0.90 [0.63-1.29],0.5809030675666452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",8023,82,0.69 [0.39-1.24],0.2148410772769956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,8972,86,1.12 [0.73-1.72],0.5990235906653258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,8972,86,1.04 [0.75-1.46],0.800713003053948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,7921,80,0.88 [0.48-1.64],0.6936421086238231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,7902,78,0.88 [0.67-1.16],0.3655718769688783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,7775,79,0.99 [0.76-1.30],0.9654296550275404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,8042,80,0.95 [0.75-1.21],0.7036799566354581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,8035,82,0.86 [0.68-1.08],0.1976619312870875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,9151,89,0.97 [0.81-1.16],0.7339386533693627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,7783,80,0.91 [0.67-1.25],0.5769305914441829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,7783,80,0.62 [0.34-1.13],0.1192192897186307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,8948,82,0.84 [0.50-1.42],0.5247682749365413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,7802,75,0.91 [0.65-1.27],0.5820031534793044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,7802,75,0.76 [0.43-1.34],0.3397436211698035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,7783,80,1.16 [0.88-1.53],0.2935273851195065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,9008,86,0.84 [0.48-1.48],0.545673265192036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,7802,75,0.45 [0.24-0.87],0.0169554845064355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,9182,88,0.85 [0.54-1.32],0.459144745845383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,9137,86,0.80 [0.56-1.14],0.2167256645396759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,9224,85,1.46 [0.83-2.58],0.1884013107618314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,7783,80,1.07 [0.79-1.44],0.6797701581290901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,9008,86,1.20 [0.83-1.74],0.3374215165931115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,7974,80,0.78 [0.47-1.29],0.3271858590653311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,9110,87,0.95 [0.66-1.35],0.7568360664838222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,9110,87,2.03 [1.11-3.73],0.0222733963578686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,8052,80,1.12 [0.51-2.50],0.7742860856010256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,8046,81,1.03 [0.50-2.16],0.927560406046934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,8035,82,0.94 [0.69-1.30],0.7219531555197469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,7871,79,0.93 [0.75-1.16],0.5377146340817339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,7802,75,0.97 [0.72-1.29],0.8229904641330853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,8948,82,0.80 [0.55-1.17],0.2432588705611904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,7775,79,1.45 [0.87-2.42],0.1514813536161077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,8011,80,0.87 [0.67-1.13],0.3102587648646785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,8972,86,0.96 [0.69-1.33],0.8077803652479005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,9214,89,0.97 [0.74-1.27],0.8257309244076636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,7802,75,0.81 [0.47-1.39],0.4518171789536974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,7802,75,1.07 [0.53-2.14],0.8518054297106522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,7802,75,0.78 [0.41-1.47],0.4401500634632846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,7775,79,0.92 [0.54-1.57],0.768974399577431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,7802,75,0.83 [0.55-1.27],0.3990583276526181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",7802,75,1.12 [0.79-1.58],0.5204689252795648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",9220,88,0.98 [0.82-1.15],0.7700581935195733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",8948,82,0.84 [0.51-1.38],0.4816372625522677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,8972,86,1.15 [0.75-1.76],0.5145895392391471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,9137,86,1.16 [0.58-2.32],0.6694488596240229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,8929,82,1.03 [0.77-1.39],0.8209043460691451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,7871,79,0.93 [0.69-1.26],0.6371701257552385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,7802,75,0.85 [0.67-1.09],0.1980421799969441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,8011,80,1.36 [0.67-2.76],0.394750701535428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",8065,80,1.30 [0.36-4.75],0.6906322617455438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,8948,82,1.01 [0.77-1.33],0.936165860871622
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,7783,80,0.96 [0.78-1.17],0.6689020235477008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,8035,82,0.91 [0.56-1.47],0.6986495205469625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,8042,80,0.94 [0.67-1.33],0.7281077693658451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,9151,89,0.94 [0.77-1.15],0.5495300441684444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,9224,85,1.45 [0.72-2.94],0.3015708131952008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,8035,82,0.76 [0.51-1.14],0.1868822332874536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,8886,83,0.87 [0.66-1.14],0.2978338431743149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,8065,80,0.77 [0.37-1.60],0.480160653335541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,7802,75,0.54 [0.17-1.74],0.3005629321588107
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",7871,79,1.46 [0.80-2.68],0.2183472461545502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",9220,88,1.73 [0.88-3.39],0.1122688545716022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",9182,88,0.81 [0.36-1.81],0.6092757120022274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,7830,79,0.65 [0.28-1.49],0.3061225449443334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,9151,89,0.94 [0.72-1.23],0.6713435501891925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,9096,87,1.18 [0.73-1.90],0.5059678467034089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,7830,79,1.00 [0.64-1.56],0.9883519976155124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,8996,83,0.82 [0.47-1.44],0.4839122774886225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,8972,86,1.09 [0.81-1.47],0.5520689316574328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,8972,86,1.06 [0.55-2.04],0.8705416652630413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,9151,89,0.94 [0.78-1.12],0.4899810233425556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,8042,80,1.03 [0.76-1.41],0.8310130223886585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,7841,81,1.05 [0.84-1.32],0.673134686090985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,8937,82,1.07 [0.86-1.34],0.5388489545582353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,9182,88,1.79 [0.85-3.79],0.1259073691704191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,9110,87,0.79 [0.45-1.37],0.3946183880466308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",8046,81,0.90 [0.44-1.85],0.770129693765436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",7783,80,1.06 [0.73-1.55],0.7425055932091205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,7907,78,0.70 [0.39-1.27],0.2407457427786505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,8011,80,0.93 [0.61-1.40],0.7110117828294168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,8042,80,0.95 [0.77-1.19],0.6689397122306902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",9151,89,0.96 [0.63-1.46],0.856214413559338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,7830,79,0.84 [0.56-1.26],0.4085445531133598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,7775,79,0.99 [0.71-1.39],0.9738906596814948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,8023,82,0.92 [0.56-1.51],0.7285992999758946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,9151,89,0.98 [0.79-1.20],0.8162954520678091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,8062,80,0.84 [0.65-1.07],0.1588079010092788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,7871,79,0.94 [0.65-1.36],0.757339566060735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,7775,79,0.89 [0.54-1.47],0.6483749173835391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,8062,80,1.07 [0.85-1.35],0.5663631458566123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,8951,86,1.05 [0.90-1.23],0.5049389810385467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,7783,80,0.92 [0.67-1.27],0.6164090314730237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,7802,75,1.63 [0.67-3.93],0.278412622425338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,9151,89,0.98 [0.74-1.29],0.8845172383941547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,9182,88,0.92 [0.75-1.14],0.4493828347377609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,8972,86,1.05 [0.77-1.42],0.7701987785003586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,9282,86,0.79 [0.47-1.35],0.3900193262232937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,7830,79,1.33 [0.83-2.11],0.2366955627570295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,7783,80,0.90 [0.65-1.24],0.5189956935897662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,8042,80,0.78 [0.44-1.38],0.3930524908087707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,9182,88,0.91 [0.69-1.21],0.5299759514463391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,7902,78,1.83 [0.84-3.98],0.1295033471398228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,9096,87,1.21 [0.81-1.81],0.3414477895190573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,8987,83,0.84 [0.53-1.31],0.4350422985949845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,7902,78,0.87 [0.33-2.28],0.770274186026595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,8046,81,1.30 [0.71-2.39],0.3982249702301603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,7830,79,0.93 [0.56-1.53],0.7675827143417709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,8996,83,1.25 [0.54-2.89],0.6030513407983298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,7783,80,1.39 [1.01-1.93],0.0463434677243605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,7871,79,0.88 [0.60-1.31],0.5297324031880621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,7592,77,0.88 [0.72-1.08],0.223159557730314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,9135,85,0.88 [0.64-1.21],0.4398297976713892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,8031,81,1.11 [0.84-1.47],0.4656547687036745
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,7934,80,0.88 [0.72-1.07],0.1986914276912984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,7921,80,1.34 [0.73-2.46],0.3397091558596395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,7783,80,1.02 [0.56-1.86],0.9473288684627256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,7802,75,1.09 [0.71-1.67],0.7087426673543447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,7802,75,1.28 [0.71-2.29],0.4091022459500882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,8948,82,0.89 [0.57-1.41],0.6274201433904674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,7783,80,0.65 [0.34-1.21],0.175025191361016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,8035,82,0.84 [0.48-1.46],0.5392229231397934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSG,Basigin,9253,87,2.95 [1.21-7.18],0.0172377831601672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSND,Barttin,7775,79,0.60 [0.28-1.28],0.1831959401679978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,9245,88,0.81 [0.59-1.12],0.1954423809789101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,9245,88,1.23 [0.89-1.70],0.2046891936814554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,8972,86,0.88 [0.67-1.15],0.343779856043652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,8065,80,1.04 [0.37-2.92],0.9457429251688404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,7775,79,1.04 [0.81-1.33],0.778641231371057
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,8008,82,0.84 [0.46-1.51],0.5564713254544882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,9220,88,1.47 [0.74-2.94],0.2703623341367384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,9151,89,0.99 [0.60-1.63],0.9694245476875422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,7775,79,0.90 [0.51-1.58],0.715543753873667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,8948,82,1.03 [0.76-1.40],0.8347041068657779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,7802,75,1.21 [0.62-2.36],0.5836736175966265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,9223,87,1.17 [0.49-2.80],0.7164604576703556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",8035,82,0.94 [0.69-1.29],0.7190084669172242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,7830,79,1.18 [0.76-1.86],0.4597395790990943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,9224,85,1.02 [0.66-1.59],0.9203933297855904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,7902,78,1.18 [0.66-2.10],0.5813762842691039
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,8035,82,0.85 [0.43-1.68],0.6384016143284355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,7885,78,0.63 [0.43-0.94],0.022955088324421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,8065,80,0.69 [0.19-2.46],0.5672491698955533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,8053,80,0.76 [0.26-2.20],0.6093829410796892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,8065,80,0.98 [0.35-2.73],0.9729167243233022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2,Complement C2,9205,85,0.73 [0.35-1.52],0.4014202529095444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,8929,82,1.19 [0.79-1.80],0.4053655430648618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,7841,81,0.88 [0.59-1.33],0.5464133093487367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C3,Complement C3,7651,72,1.19 [0.75-1.89],0.4618415602692675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,9214,89,0.71 [0.45-1.12],0.1395937276822922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C5,Complement C5,8065,80,0.89 [0.21-3.76],0.8701939193429815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,7854,73,0.51 [0.26-1.01],0.0552082718073367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,8042,80,0.83 [0.28-2.43],0.7348339832737651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,8065,80,0.54 [0.27-1.07],0.0769251603579063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,8052,80,0.85 [0.56-1.29],0.4454864452261554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,8011,80,0.98 [0.76-1.27],0.9046115708696116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,8987,84,0.90 [0.66-1.23],0.5098113608084383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,8972,86,1.05 [0.60-1.83],0.8721934299704796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,9137,86,1.63 [0.92-2.88],0.0917546977944492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,9095,87,0.96 [0.80-1.15],0.676033306183256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,9252,88,0.87 [0.50-1.52],0.6224825216758926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,9148,88,0.90 [0.69-1.18],0.4492342923551597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,9268,86,1.04 [0.77-1.42],0.7863543697196146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,9282,86,1.44 [0.64-3.24],0.3763787089019039
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",8996,83,1.09 [0.88-1.34],0.4339887773890858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,9148,87,0.81 [0.60-1.09],0.1694423977363653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,7921,80,0.73 [0.37-1.43],0.3540890278794445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,7830,79,1.20 [0.69-2.08],0.5176430490954564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,9252,88,1.19 [0.81-1.74],0.3815827094615441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,7841,81,1.06 [0.77-1.46],0.7266396122769191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,7783,80,1.76 [1.14-2.72],0.010596380251331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,7802,75,0.96 [0.65-1.43],0.854138346584137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,7783,80,0.81 [0.54-1.21],0.3000639284498454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,8035,82,0.96 [0.75-1.24],0.770272750504802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,7888,78,0.96 [0.77-1.19],0.7033514236640024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,7841,81,0.80 [0.45-1.43],0.4588074482650693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,9137,86,1.46 [0.92-2.31],0.1059421964428808
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,8948,82,0.93 [0.49-1.77],0.8273277302383211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,9091,87,1.22 [0.90-1.66],0.1937401230632193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,8042,80,1.20 [0.77-1.88],0.4247468890809377
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,9220,88,0.93 [0.77-1.11],0.4086230250799582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,7871,79,0.88 [0.66-1.17],0.370170139058828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,7802,75,1.13 [0.68-1.88],0.6364271499385992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,8972,86,0.83 [0.52-1.33],0.4389457137214493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,7841,81,0.94 [0.63-1.40],0.7692439038880223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,8035,82,0.93 [0.76-1.13],0.4666845500840239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,9139,88,1.08 [0.42-2.76],0.8690140070598856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,9105,87,1.10 [0.79-1.53],0.5604340438141535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,8023,82,1.22 [0.77-1.93],0.3966476931826587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,8042,80,0.97 [0.78-1.20],0.7624673331293244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,8948,82,1.09 [0.76-1.57],0.6390750118459829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,7841,81,0.94 [0.55-1.60],0.8099357521338233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,8948,82,0.82 [0.61-1.10],0.1890691284914163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,8948,82,1.05 [0.79-1.39],0.7366546530725548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,9151,89,0.94 [0.71-1.24],0.6417386470374564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,9282,86,0.97 [0.78-1.20],0.749499226313234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,7921,80,0.97 [0.85-1.10],0.6079356162402941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,8042,80,0.90 [0.69-1.16],0.4067747299689195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,9217,88,0.93 [0.68-1.26],0.6294016830405904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,7830,79,0.96 [0.66-1.37],0.8050085611620401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,7802,75,1.30 [0.92-1.84],0.1347816408390257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAT,Catalase,7935,79,1.02 [0.69-1.49],0.9358151967958996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,9157,88,1.11 [0.87-1.42],0.3969904459867067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,7783,80,1.06 [0.87-1.30],0.5429954357328781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,9252,88,1.26 [0.71-2.26],0.4292567295666143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,7871,79,1.26 [0.86-1.85],0.2333424206403237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,7802,75,0.97 [0.57-1.68],0.9258689339907772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,9110,87,0.97 [0.74-1.26],0.7984959233021439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,8042,80,0.81 [0.51-1.31],0.3945391895106118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,8023,82,0.90 [0.58-1.40],0.6370904247674378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,7841,81,0.58 [0.28-1.22],0.1497920592258552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,8035,82,0.86 [0.64-1.17],0.3425072730105836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,9173,88,1.28 [0.78-2.09],0.3276828408827614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,7871,79,1.38 [1.02-1.88],0.0397897585515934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,9266,87,0.80 [0.47-1.35],0.3992782136152439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,9247,87,0.97 [0.73-1.28],0.8199040132915727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,9168,85,0.97 [0.59-1.59],0.8943227175340093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,9282,86,1.04 [0.67-1.61],0.8519315785796446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,9282,86,1.22 [0.84-1.78],0.2968116892742439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,9172,88,0.87 [0.71-1.07],0.1962217868815937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,9054,84,1.06 [0.81-1.40],0.6584670298052089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,9245,88,1.04 [0.92-1.18],0.517154060726568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,9096,87,0.91 [0.64-1.31],0.6204870317334208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,9266,87,1.05 [0.87-1.28],0.6041096582360244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,9220,88,1.11 [0.75-1.66],0.5954858077425819
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,9105,88,1.23 [0.86-1.74],0.257049734000445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,9220,88,1.28 [0.82-2.02],0.2804144173218024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,9202,88,1.08 [0.86-1.36],0.4869834221575216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,9266,87,0.76 [0.51-1.14],0.19027390031088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,9151,89,0.94 [0.75-1.16],0.5448409014914202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,9173,88,1.07 [0.77-1.48],0.7029243208681792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,9115,88,0.77 [0.54-1.08],0.1294676937352992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,9151,89,1.04 [0.77-1.40],0.7938965648499642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,9202,88,0.88 [0.65-1.18],0.387275733741335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,9224,85,1.07 [0.88-1.30],0.4983593498289989
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,9151,89,1.13 [0.84-1.52],0.4360569335274288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,9235,88,0.91 [0.67-1.24],0.5424427457491545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,9116,86,1.18 [0.91-1.54],0.2025034193407225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,9165,88,0.85 [0.61-1.20],0.3573026433436856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,9266,86,1.35 [0.79-2.30],0.2710830749018339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,9252,88,1.25 [0.80-1.94],0.3203678303183221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,9182,88,1.23 [0.76-1.99],0.4051929829128007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,7921,80,1.12 [0.62-2.02],0.7052807491647923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,7830,79,0.86 [0.63-1.18],0.3562964342895049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,9110,87,0.93 [0.62-1.38],0.7168792307323084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,8972,86,1.01 [0.65-1.55],0.9739460185893782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,8011,80,0.74 [0.46-1.19],0.2111771392274301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,9182,88,1.32 [0.74-2.34],0.3473695091216927
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,9011,84,1.35 [0.85-2.15],0.2011112688456746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,9266,87,1.09 [0.74-1.63],0.6563795585062178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,9224,85,1.31 [0.84-2.04],0.2278577613013076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,9182,88,1.17 [0.61-2.25],0.6346466457927824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,7841,81,1.10 [0.62-1.96],0.734020864339623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,9173,88,1.01 [0.87-1.17],0.9163506241106942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,9214,89,1.19 [0.55-2.61],0.6549052895190861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,7802,75,0.81 [0.42-1.56],0.5247735972811288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,9151,89,0.86 [0.41-1.79],0.6876638026297679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,9120,89,0.45 [0.25-0.79],0.0053641254936329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,8958,86,1.07 [0.65-1.76],0.7877693402524311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,9202,86,1.29 [0.80-2.07],0.293936067976802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,9266,87,1.58 [1.02-2.44],0.0398675928058341
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,7830,79,0.79 [0.46-1.34],0.3782342404806683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,9266,87,1.50 [0.74-3.04],0.2561421304852584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,8062,80,1.24 [0.73-2.11],0.428459036237192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,9214,89,1.31 [0.84-2.03],0.2358803263806732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,9110,87,1.37 [0.81-2.33],0.2395189758289898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,9173,88,1.26 [0.73-2.15],0.4033902191178543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,8972,86,0.90 [0.53-1.53],0.6973095532339407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,9173,88,1.00 [0.74-1.33],0.9740886119202172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,7902,78,1.14 [0.56-2.34],0.7162395826145502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,9245,88,2.03 [1.22-3.38],0.006673812804387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,9217,88,1.10 [0.70-1.74],0.6724024603662987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,9252,88,0.77 [0.59-1.02],0.0712997374525425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,9182,88,1.04 [0.63-1.72],0.8789052416844815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,9137,86,0.95 [0.51-1.80],0.8804099907887758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,9214,89,0.88 [0.70-1.10],0.2585152540098943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,9221,88,1.32 [0.60-2.92],0.4892930174938108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,7830,79,0.97 [0.59-1.60],0.9038931945888584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,9137,86,0.98 [0.53-1.79],0.9382894236258684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,7783,80,1.15 [0.61-2.17],0.6666547608555324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,7921,80,0.97 [0.54-1.75],0.9121754212580334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,7830,79,0.92 [0.71-1.20],0.5404852694113835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,9133,89,0.96 [0.52-1.78],0.8996770915203368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,9184,88,1.00 [0.68-1.47],0.9802358086694776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,9266,87,0.94 [0.74-1.21],0.6428748335626789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,9141,85,1.22 [0.62-2.41],0.5555588173316985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,9202,88,0.86 [0.45-1.63],0.6475007963466386
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,9235,88,1.26 [0.71-2.21],0.4298873420127248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,8869,82,1.63 [0.79-3.35],0.1827071811335229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,9167,88,0.51 [0.18-1.46],0.2106131182474734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,8859,84,1.59 [0.73-3.43],0.2406454499020888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,8014,79,0.85 [0.53-1.35],0.4861423730563603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,9253,87,1.09 [0.77-1.56],0.6210934633795864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,9096,87,0.83 [0.58-1.20],0.3232715847218236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,9147,88,0.97 [0.78-1.21],0.7808433913703009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,7811,79,1.19 [0.73-1.93],0.4775697342173766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,9151,89,1.13 [0.72-1.77],0.5951763121567302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,7902,78,0.98 [0.58-1.64],0.9397064548418106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,9245,88,1.32 [0.78-2.23],0.3048720525066316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,9266,87,1.20 [0.79-1.82],0.3962961123808376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,8046,81,1.47 [0.80-2.72],0.2162324959918475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,7921,80,0.86 [0.49-1.49],0.5861416839802244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,9151,89,1.03 [0.59-1.79],0.9242133576317796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,9151,89,0.73 [0.40-1.33],0.305037688971108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,8011,80,0.77 [0.36-1.66],0.5066332134839882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,9245,88,0.84 [0.57-1.24],0.3790900025885166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,8838,82,1.46 [0.79-2.69],0.2284395089234546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,9182,88,0.61 [0.22-1.64],0.3231848662678325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,9182,88,0.86 [0.38-1.94],0.7119191912305234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,8026,81,1.26 [0.82-1.93],0.2852101994870437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,8042,80,1.00 [0.42-2.39],0.9997283797730732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,7775,79,0.77 [0.52-1.14],0.1859662360042644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,7775,79,0.65 [0.35-1.20],0.1663580159733918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,7997,80,0.95 [0.69-1.30],0.7329560822311478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,8972,86,0.77 [0.55-1.09],0.1394713740666121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,9214,89,0.98 [0.78-1.23],0.8829899520441794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,8011,80,0.89 [0.72-1.11],0.3058754521265929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,9110,87,1.26 [0.88-1.80],0.2144098267224302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,8889,81,1.09 [0.67-1.79],0.7204196310747335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,9226,88,1.46 [1.05-2.03],0.0226652936374683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,9173,88,0.79 [0.59-1.06],0.1141200511267308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,9173,88,1.64 [0.97-2.80],0.0672812610724595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,7921,80,1.78 [1.03-3.08],0.038443512937282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,8042,80,0.97 [0.43-2.20],0.9467348247888722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,9245,88,2.23 [1.50-3.32],7.683012968806964e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,7783,80,0.81 [0.49-1.32],0.3950241939872434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,9282,86,1.21 [0.65-2.24],0.5522180957542939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,9173,88,1.91 [1.17-3.11],0.0094105488777618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,8948,82,1.20 [0.79-1.83],0.3921434545131267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,9137,86,0.99 [0.77-1.28],0.9598784070303809
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,9173,88,0.85 [0.53-1.36],0.4970090971555337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,7775,79,1.27 [0.70-2.28],0.4337014372675954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,8035,82,1.18 [0.83-1.67],0.365002680419991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,7783,80,1.00 [0.67-1.48],0.9994058620680166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,9137,86,1.00 [0.83-1.20],0.9978678867012982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,9137,86,0.95 [0.77-1.16],0.5890374743905493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,9137,86,0.90 [0.50-1.64],0.7381165498616414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,9190,88,1.36 [0.64-2.86],0.4243789472128384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,9229,86,1.19 [0.77-1.83],0.4381410935223552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,9198,89,0.61 [0.27-1.37],0.2341315305888856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,8011,80,0.88 [0.66-1.17],0.3850886852032955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,7921,80,1.05 [0.78-1.40],0.7542872584623508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,8011,80,0.95 [0.56-1.62],0.8542498373311673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,7921,80,0.93 [0.57-1.52],0.7659201968456069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,9151,89,0.91 [0.73-1.14],0.4128767049453062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,8972,86,1.17 [0.82-1.68],0.3804082685545962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,8868,84,0.94 [0.70-1.27],0.7042741160928221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,8062,80,1.19 [0.68-2.06],0.5409447861900379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,8996,83,1.09 [0.74-1.61],0.6489024568459578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,7830,79,0.99 [0.55-1.79],0.9727789427551656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,8996,83,0.96 [0.58-1.61],0.8897723476782406
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,8062,80,1.01 [0.70-1.44],0.9635549282412478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,9266,86,0.82 [0.59-1.14],0.2417116137030223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,7902,78,0.78 [0.36-1.68],0.5297848965946579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,7830,79,1.69 [1.27-2.24],0.0003320660059274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,7783,80,1.17 [0.87-1.57],0.2929624909120312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,7921,80,1.02 [0.69-1.50],0.9229394245249016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,7921,80,0.92 [0.67-1.28],0.6278876874344368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,7802,75,0.62 [0.31-1.24],0.1758018836498736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,7775,79,0.90 [0.52-1.55],0.7005486643789416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,9008,86,0.86 [0.60-1.22],0.4003885311591451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,7871,79,0.77 [0.56-1.04],0.091259249844876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,8972,86,1.12 [0.87-1.45],0.3704901705249661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,7921,80,0.92 [0.60-1.42],0.7198697010930912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,7775,79,0.91 [0.51-1.63],0.7506734280642284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,8927,82,0.99 [0.74-1.32],0.9305313764793286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,8972,86,0.99 [0.73-1.34],0.9527270240615002
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,8948,82,1.15 [0.83-1.58],0.4039826396081353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,9200,86,1.20 [0.95-1.51],0.118048118138958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,9137,86,0.75 [0.52-1.08],0.1192480486781401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,9137,86,1.03 [0.79-1.34],0.828408958267526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,8948,82,0.97 [0.72-1.31],0.8569265771139141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,8011,80,0.94 [0.70-1.25],0.6718669995910853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,7914,76,0.93 [0.47-1.86],0.8391000441219381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,8972,86,1.03 [0.66-1.60],0.8932088427192637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,8065,80,1.24 [0.44-3.51],0.685852295347327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,7577,72,1.48 [0.55-3.97],0.43468929831109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,8004,80,0.96 [0.66-1.38],0.8109818566916381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,8051,80,0.98 [0.73-1.30],0.8807525425432743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,7934,79,1.02 [0.61-1.72],0.9306578094088928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,8065,80,1.32 [0.45-3.88],0.6183463210753901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFP,Properdin,8065,80,1.48 [0.63-3.50],0.366358501664356
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,9182,88,1.06 [0.77-1.46],0.7278211024105956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,8052,80,0.95 [0.54-1.66],0.8548753123945019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,7841,81,1.38 [0.96-1.99],0.0834652500610717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,9173,88,1.44 [0.93-2.22],0.1009315722880078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,8972,86,0.77 [0.55-1.07],0.1211456645603738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,7902,78,0.93 [0.62-1.39],0.7189449383641713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",8042,80,1.16 [0.68-1.99],0.5845435241273385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,8023,82,0.87 [0.39-1.95],0.7359170115347373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,8996,83,1.09 [0.61-1.95],0.7639491426281333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,8062,80,1.19 [0.99-1.45],0.0707510138523491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,9211,88,1.21 [0.76-1.91],0.4209361251908072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,9006,84,1.34 [1.07-1.68],0.0097337650697216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,9219,86,1.02 [0.90-1.17],0.7432589284831927
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,9212,85,0.89 [0.47-1.69],0.7150222706694551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,7841,81,0.86 [0.60-1.25],0.4312921093462516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,9110,87,0.92 [0.72-1.17],0.4852403484136461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,8046,81,0.90 [0.61-1.33],0.5878949056443789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,7783,80,1.02 [0.76-1.36],0.9155108789285208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,9202,88,0.94 [0.51-1.76],0.8545912747759058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,9173,88,1.48 [1.01-2.18],0.0454314385669276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,7841,81,0.93 [0.52-1.70],0.8248002510628144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,9214,89,0.93 [0.69-1.26],0.6419290101874452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,8062,80,0.74 [0.51-1.06],0.1028141530669161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,7921,80,0.78 [0.44-1.36],0.3783914104379487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,8011,80,0.92 [0.73-1.15],0.4606447991031215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,7841,81,1.14 [0.72-1.81],0.5671183947736081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,9235,87,1.99 [1.12-3.52],0.0184208357575526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,8062,80,0.80 [0.56-1.14],0.2199829864900484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",9161,88,0.94 [0.73-1.20],0.6258088194480814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,7775,79,0.92 [0.67-1.27],0.6162086825512734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,9156,88,0.99 [0.74-1.33],0.970410597547998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,9110,87,1.11 [0.65-1.87],0.7054330983234229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,9163,88,0.90 [0.61-1.33],0.5994924823358172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,7830,79,0.96 [0.34-2.77],0.9457600449818512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,9182,88,1.02 [0.56-1.85],0.9450563140835258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,8996,83,0.83 [0.46-1.51],0.5441656368494797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,9245,88,0.94 [0.77-1.14],0.5169649397563978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,7841,81,0.86 [0.53-1.39],0.5300894417781112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,7863,75,0.98 [0.34-2.83],0.9722757580575716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,9151,89,0.64 [0.38-1.07],0.0896068469084665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,9151,89,0.80 [0.53-1.19],0.2648938702917935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,9151,89,1.10 [0.81-1.48],0.5424908381043398
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,9151,89,0.98 [0.55-1.73],0.931882996318368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,8049,80,1.15 [0.75-1.78],0.5172119839802867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,9156,88,1.12 [0.59-2.13],0.7191548791725668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,8972,86,0.82 [0.54-1.25],0.3591916274601318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,9266,87,1.12 [0.79-1.59],0.5216982433153318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,7841,81,0.79 [0.48-1.33],0.3778935739405544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,7841,81,0.38 [0.20-0.70],0.0022476655304283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,7775,79,1.14 [0.77-1.67],0.5133712667370254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,9151,89,0.98 [0.83-1.16],0.851061327088189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,9252,88,1.34 [0.53-3.38],0.5355589211558848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,7841,81,0.57 [0.28-1.15],0.1165140719014976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",9091,87,1.08 [0.89-1.32],0.4437838214677925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,9168,88,1.19 [0.91-1.57],0.2095380257171386
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,8929,82,1.28 [0.78-2.10],0.3258114737488556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,8948,82,0.93 [0.63-1.38],0.7286423372995369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,9266,87,1.04 [0.64-1.69],0.8752123840400224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,8042,80,1.84 [0.97-3.46],0.0601729045056499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,8996,83,0.96 [0.64-1.45],0.8476637630701409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,8065,80,0.99 [0.48-2.04],0.9889970736750124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,9158,88,1.16 [0.76-1.76],0.4863582590010735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,8046,81,0.97 [0.77-1.23],0.8024711049395059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,8023,82,0.86 [0.67-1.12],0.2678516079765024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,9224,85,0.85 [0.57-1.28],0.4452734533660355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,7783,80,1.22 [0.90-1.67],0.1981389686701982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",7858,79,0.90 [0.68-1.19],0.4572847309010427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,8996,83,0.90 [0.63-1.27],0.5432654483179025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,9137,86,0.99 [0.77-1.29],0.9657748155170588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNST,Consortin,9173,88,0.97 [0.82-1.16],0.7621740959991137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,7783,80,1.33 [0.72-2.43],0.3634762357875571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,9282,86,0.80 [0.40-1.58],0.5118972998077347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,9252,88,0.81 [0.53-1.25],0.3370363316396204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,9182,88,1.14 [0.65-1.98],0.6520790623714066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,9182,88,0.94 [0.42-2.08],0.8722470246304143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,9192,88,0.78 [0.47-1.30],0.343754802574715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,9151,89,0.95 [0.59-1.53],0.8263117524777505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,7841,81,1.06 [0.88-1.29],0.5270944886121269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,8046,81,0.97 [0.61-1.53],0.8867488335092306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,8062,80,0.89 [0.40-1.99],0.7767811800631967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,9223,86,1.48 [0.65-3.34],0.3484795104092121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,9282,86,1.43 [0.70-2.93],0.3313437600245636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,8011,80,0.81 [0.56-1.18],0.2776130436290458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,7841,81,0.88 [0.65-1.19],0.4112528475270424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,7871,79,0.91 [0.69-1.19],0.4987385445926744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,8062,80,0.99 [0.39-2.52],0.9789272638332948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,9173,88,1.03 [0.64-1.66],0.9156246736601924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,7907,80,1.16 [0.76-1.78],0.4892672901713323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,7902,78,1.25 [0.74-2.11],0.406569362617985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,9282,86,1.34 [0.80-2.26],0.2710438798877047
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,9151,89,0.79 [0.53-1.16],0.226617940116057
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,7921,80,0.74 [0.43-1.28],0.2792636973914917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,9173,88,1.47 [0.73-2.98],0.2838314782569006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,7871,79,0.82 [0.57-1.18],0.2833455329105764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,8023,82,0.98 [0.57-1.67],0.9342601860995616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,9082,85,0.68 [0.38-1.21],0.1906242857869653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,8910,83,0.96 [0.76-1.22],0.7636207111132041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',7802,75,0.79 [0.46-1.36],0.3962226113877293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,8948,82,0.94 [0.60-1.48],0.7984931937409558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",7871,79,0.92 [0.55-1.54],0.7436615457696121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,8977,83,0.92 [0.74-1.15],0.464869528600442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,7783,80,1.17 [0.67-2.05],0.5882081590874382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",9137,86,0.99 [0.75-1.30],0.9375405233296346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,8046,81,1.04 [0.54-1.98],0.9148683078362976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,9282,86,0.94 [0.68-1.31],0.7215128656461316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,9212,88,1.09 [0.82-1.45],0.5564507129885494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,7750,77,1.39 [0.83-2.32],0.20762694348701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,9282,86,0.94 [0.68-1.31],0.7206334731406059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,8047,79,0.64 [0.24-1.71],0.3732764399045212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,9178,88,1.22 [0.72-2.05],0.4633780479194845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,7775,79,0.82 [0.40-1.71],0.604524451489352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,9197,88,1.23 [0.71-2.14],0.453631559355768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",7830,79,0.93 [0.43-2.05],0.8642990263491206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,9245,88,0.95 [0.72-1.26],0.7290565536895464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,8040,80,0.71 [0.40-1.25],0.2318456374152545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,7802,75,1.54 [0.97-2.45],0.0647615903924805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,9243,88,0.83 [0.53-1.31],0.4330081606982155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,9214,89,0.96 [0.74-1.25],0.7504983683319473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,8046,81,0.93 [0.41-2.11],0.8637394804873813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,8022,80,1.42 [0.78-2.59],0.2566342179274608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,9224,85,1.08 [0.71-1.62],0.726130622911071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,8972,86,0.91 [0.72-1.14],0.4032918133404354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,9091,87,0.99 [0.77-1.27],0.9189182284812608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,7775,79,1.10 [0.77-1.59],0.591789137319636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,7775,79,1.36 [0.62-2.96],0.4414773503018089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,9071,88,0.96 [0.56-1.63],0.8791367663377947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,7902,78,1.54 [0.87-2.72],0.141415981709314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,9202,88,1.02 [0.71-1.47],0.9218833131479878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,8955,86,0.95 [0.76-1.20],0.691447674136766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,9173,88,1.34 [0.68-2.64],0.4030732230789092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,8996,83,1.12 [0.84-1.48],0.439368614266687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,9220,88,1.59 [0.63-3.99],0.3239841938441391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,9110,87,1.35 [0.85-2.15],0.1999466758957948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,9252,88,1.16 [0.86-1.58],0.3349150216867714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,7986,80,0.89 [0.40-1.95],0.7641482384229177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,9196,88,0.93 [0.78-1.12],0.4590053557587453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,9220,88,1.50 [0.69-3.25],0.3021048867915195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,8948,84,0.99 [0.75-1.31],0.9307724782016948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,9282,86,0.99 [0.52-1.89],0.969512297260424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,9110,87,0.95 [0.66-1.38],0.7925858700228531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,7841,81,0.76 [0.45-1.28],0.3047515930970101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,8996,83,1.11 [0.96-1.29],0.1695585559732801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,8046,81,0.88 [0.63-1.24],0.4720728208775709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,8042,80,1.07 [0.85-1.35],0.5618414862710255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,8042,80,0.80 [0.64-0.99],0.0423465159032606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,7783,80,0.95 [0.71-1.27],0.7443030390098989
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,7871,79,0.90 [0.71-1.14],0.3858296315408436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,7802,75,0.96 [0.79-1.18],0.7083241523740325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,9220,88,1.91 [1.01-3.63],0.0475608334396517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,8052,80,1.29 [0.75-2.23],0.3557482258196576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,7802,75,0.97 [0.51-1.85],0.9325254064500884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,9110,87,0.89 [0.65-1.23],0.4875561361304895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,7830,79,1.39 [0.83-2.32],0.2104479900643015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,9008,86,0.79 [0.53-1.19],0.2642806250298079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,7830,79,0.86 [0.41-1.80],0.6864628520449321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,8052,80,1.32 [0.62-2.78],0.4732849076734947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,7830,79,1.03 [0.73-1.45],0.8597084885829828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,8035,82,0.92 [0.57-1.48],0.7238530767296747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,8062,80,0.87 [0.44-1.69],0.6744681028751746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,7783,80,0.89 [0.56-1.40],0.6114913119649648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,7802,75,1.02 [0.81-1.28],0.8822993732676293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,7014,71,0.93 [0.74-1.16],0.5249469258348027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,9210,85,1.24 [0.64-2.40],0.5308278880290569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,9017,87,0.96 [0.68-1.35],0.8249900021298898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,8940,86,1.12 [0.75-1.67],0.589369118817894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,9202,88,1.14 [0.97-1.34],0.1009041300550528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,9057,85,1.11 [0.70-1.76],0.6614918483100665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,7904,80,1.34 [0.91-1.96],0.1337873516748329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,7929,80,0.64 [0.33-1.26],0.1979185139221319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,8996,83,1.00 [0.79-1.26],0.9690654582325976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,8062,80,1.16 [0.56-2.41],0.6868036218235636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,8062,80,0.71 [0.34-1.49],0.3675668650263243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,7783,80,1.02 [0.59-1.78],0.9348095958673376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,9182,88,0.90 [0.64-1.27],0.5506048967167523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,9182,88,0.80 [0.60-1.07],0.1378058320274474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,8042,80,1.05 [0.77-1.44],0.7519198601860402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,9199,85,1.18 [0.84-1.67],0.3342572503897227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,9164,87,1.08 [0.70-1.68],0.7222935233766643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,8604,77,1.11 [0.67-1.82],0.693790401045195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,7902,78,1.03 [0.67-1.58],0.8997650430398604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,9214,89,0.75 [0.47-1.21],0.2422901583802235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,8973,83,0.88 [0.68-1.16],0.3673892666150949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,9173,88,1.11 [0.52-2.39],0.7893919115227177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,9266,87,0.68 [0.36-1.30],0.2465227529908913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,7150,75,2.41 [1.02-5.69],0.0455825260347298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,9226,88,0.65 [0.41-1.04],0.0722878747062191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,9203,85,0.94 [0.51-1.73],0.8379558591543252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,7841,81,1.57 [1.05-2.33],0.0272257074057789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,7956,79,1.08 [0.77-1.51],0.6733106625892943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,9110,87,1.56 [0.90-2.68],0.1098868864582493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,9151,89,0.74 [0.51-1.09],0.1239710234314396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,9177,88,0.89 [0.73-1.09],0.271962946476824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,9220,88,1.08 [0.82-1.41],0.5835539012077895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,9245,88,0.88 [0.69-1.13],0.3115454061340092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,9008,86,0.83 [0.51-1.36],0.4652021196057535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,9245,88,1.20 [0.93-1.53],0.1553108834047241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,9008,86,1.06 [0.78-1.43],0.7072804158795073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,9273,86,2.25 [1.02-4.95],0.0436513254648326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,9266,87,0.79 [0.49-1.26],0.3207722689195771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,9184,88,0.95 [0.77-1.16],0.588824209076278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,9147,88,1.02 [0.87-1.21],0.7675332179423731
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,9266,87,0.93 [0.72-1.19],0.5536296807300777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,9107,84,0.87 [0.65-1.17],0.3707226695152499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,9220,88,0.98 [0.74-1.30],0.9103491920334416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,7775,79,0.89 [0.64-1.24],0.4867451501317278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,7918,80,0.84 [0.56-1.26],0.3982682739859703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",7802,75,1.17 [0.94-1.45],0.1508342090046653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,7775,79,1.14 [0.87-1.49],0.3487060834883092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,8062,80,2.06 [0.86-4.95],0.1068115380677421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,7902,78,0.96 [0.74-1.25],0.7828796418463762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,9252,88,1.06 [0.90-1.26],0.4758249388786485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,9220,88,0.90 [0.60-1.37],0.6332367567725681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,7830,79,0.72 [0.48-1.09],0.1185091149023862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,7830,79,0.87 [0.57-1.33],0.518255699932969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,9151,89,0.98 [0.84-1.15],0.8029141386059334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",9091,87,0.94 [0.72-1.22],0.6233268559390173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,8032,80,1.10 [0.88-1.38],0.3842297963204599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,9144,87,0.90 [0.70-1.16],0.4071425871057224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,7830,79,0.70 [0.44-1.12],0.138509277687209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,9220,88,0.94 [0.77-1.15],0.5523780548819487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",9214,89,1.74 [1.02-2.95],0.0402837218134262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,7841,81,0.72 [0.25-2.07],0.5453594127420329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,7775,79,0.81 [0.56-1.18],0.2745377963697651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,7775,79,1.10 [0.55-2.19],0.7899973383751734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCN,Decorin,8996,83,1.28 [0.56-2.91],0.5593585356263475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,7902,78,0.94 [0.74-1.19],0.6088825041751922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,9252,88,1.09 [0.82-1.46],0.5344373784754486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,9137,86,1.00 [0.81-1.22],0.9782452624111554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,8948,82,0.87 [0.65-1.17],0.3652788879865972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,9173,88,1.11 [0.60-2.06],0.7476669719101611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,7783,80,1.01 [0.76-1.34],0.927628027700213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,7775,79,1.02 [0.79-1.32],0.8715850439561504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,9214,89,0.92 [0.64-1.34],0.6644159317159429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,7802,75,1.00 [0.58-1.73],0.9959263970446752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",9137,86,0.92 [0.59-1.43],0.710347431558089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,9157,88,0.66 [0.44-0.98],0.0381399601998276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,8035,82,0.89 [0.64-1.23],0.4720943905840777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,7902,78,0.88 [0.67-1.16],0.3622253789340108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,9245,88,4.85 [2.36-9.96],1.760946861036076e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,8062,80,1.00 [0.60-1.67],0.9922557293259394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,8011,80,1.01 [0.66-1.55],0.9532007050987455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,7841,81,0.60 [0.30-1.19],0.1423583646590759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,7830,79,0.69 [0.25-1.87],0.4625388462234175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,7830,79,0.77 [0.48-1.24],0.286479304311048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,7841,81,0.50 [0.27-0.93],0.0289985904356391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,8972,86,0.83 [0.57-1.21],0.3267518187649939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",9151,89,0.99 [0.81-1.20],0.8913231761611831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,9005,81,1.12 [0.79-1.57],0.5289960839370109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,7761,78,0.89 [0.50-1.59],0.7037140398692744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,7783,80,0.60 [0.36-0.99],0.0472803885051146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,7783,80,0.83 [0.60-1.16],0.2699570531532149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,7783,80,0.57 [0.32-1.02],0.0581802836765449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,9061,85,0.99 [0.87-1.13],0.8703157043631747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,7802,75,1.03 [0.68-1.54],0.9000424787613417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,7830,79,0.93 [0.62-1.38],0.7082437727456206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,9266,87,0.97 [0.73-1.28],0.8112642331404294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,7783,80,1.09 [0.69-1.71],0.7124428176636399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,7830,79,0.92 [0.61-1.38],0.6806324953289088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,9008,86,0.95 [0.54-1.67],0.8641411996821784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,7802,75,1.08 [0.70-1.66],0.7214947832248353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,8023,82,1.19 [0.76-1.88],0.4453783173533427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,8042,80,1.06 [0.67-1.69],0.8017526785552507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",9156,88,1.01 [0.85-1.20],0.9016303848780124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,7841,81,1.02 [0.62-1.69],0.9419114410987328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,7902,78,1.07 [0.47-2.46],0.8723037153547186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,9245,88,0.89 [0.65-1.23],0.4829357527601048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,9282,86,1.05 [0.56-1.98],0.8821833352555405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,9102,87,1.58 [1.12-2.23],0.009080042098526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,9137,86,0.93 [0.76-1.14],0.4822434567909781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,8042,80,0.95 [0.70-1.30],0.7675229794278644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,8035,82,0.88 [0.56-1.38],0.5834270953276997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,9282,86,1.19 [0.83-1.71],0.3509719556564317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,9214,89,1.60 [0.88-2.91],0.1264696708251008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,7871,79,0.85 [0.59-1.22],0.3779309297269098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,7871,79,0.78 [0.48-1.26],0.3104909284848617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,7871,79,1.08 [0.76-1.53],0.6681628078771451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,7775,79,1.20 [0.79-1.81],0.3903178318105539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,9248,87,1.02 [0.81-1.29],0.8459357377454318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,8042,80,1.04 [0.78-1.40],0.7686685991871733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,9137,86,0.99 [0.80-1.23],0.9493392062137876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,8011,80,0.82 [0.57-1.16],0.2628589920619719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,7902,78,0.89 [0.59-1.34],0.5805391568213993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,7828,78,0.97 [0.74-1.26],0.791411748343591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,8996,83,0.98 [0.70-1.36],0.889874060991069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,8042,80,0.84 [0.46-1.51],0.5530202935745603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,7871,79,0.94 [0.72-1.23],0.6552529002206063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,8011,80,0.98 [0.74-1.30],0.9058810243549282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,9162,88,0.43 [0.20-0.94],0.0341955597641644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,7783,80,1.05 [0.86-1.30],0.6203399551819009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,8011,80,0.99 [0.82-1.19],0.8970060156471527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,8035,82,1.01 [0.68-1.49],0.9782750542791132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,9110,87,0.96 [0.70-1.31],0.787210874178596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,8042,80,1.52 [1.04-2.21],0.0288797688537873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,9214,88,0.86 [0.60-1.23],0.4042958442515831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,7841,81,0.66 [0.32-1.38],0.2729674172717982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,7783,80,0.87 [0.70-1.07],0.1926350379253071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,8042,80,0.92 [0.78-1.07],0.2867462430306235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,9173,88,0.97 [0.83-1.14],0.7423258907697918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,9091,87,1.02 [0.70-1.47],0.9242384992770132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,9137,86,0.47 [0.24-0.93],0.0313013819377881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,9151,89,1.08 [0.63-1.85],0.7839973385192449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,9033,83,0.62 [0.31-1.24],0.1793774668619177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,9137,86,0.57 [0.32-1.02],0.0571804460649553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,9100,88,0.91 [0.66-1.26],0.5614335201082432
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,9282,86,0.64 [0.32-1.28],0.2058891888903636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,9219,88,1.16 [0.86-1.57],0.3409847541438778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,9110,87,1.26 [0.82-1.94],0.2954730354266153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,9137,86,0.85 [0.60-1.21],0.3652140266468913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,9083,85,1.28 [0.73-2.25],0.3897872562428435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,8035,82,1.09 [0.60-1.99],0.7834105576766798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,9182,88,1.56 [0.78-3.10],0.208510591176525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,9223,88,1.64 [0.94-2.88],0.0823117930149311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,9111,86,1.26 [0.87-1.83],0.219878541936605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,7902,78,0.97 [0.75-1.25],0.821988668352182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,8009,82,0.95 [0.56-1.62],0.8474300453734145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,7841,81,0.95 [0.66-1.35],0.7605854751568146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,9137,86,0.98 [0.43-2.21],0.9636539925930702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,8046,81,0.97 [0.71-1.33],0.8621757835243155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,8996,83,1.20 [0.96-1.50],0.1173138697859962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,8023,82,0.87 [0.51-1.48],0.6022602108217845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,7841,81,1.15 [0.86-1.54],0.3361743904829778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,8948,82,1.17 [0.97-1.41],0.1063496054302185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",8011,80,0.98 [0.79-1.21],0.8626755883922105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,8042,80,0.91 [0.56-1.47],0.697763469299922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,8023,82,0.96 [0.60-1.52],0.8513907634874015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,7841,81,1.07 [0.83-1.38],0.5883916738884645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,8023,82,1.06 [0.66-1.71],0.8129502167672727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,9110,87,1.00 [0.82-1.23],0.9758792610236152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,9234,88,0.99 [0.53-1.86],0.976515149964886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,8948,82,0.63 [0.36-1.11],0.1064719975606738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",8046,81,0.96 [0.71-1.29],0.7886812818878964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",7871,79,1.02 [0.81-1.28],0.8787208994317094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,7802,75,1.04 [0.73-1.49],0.8098982493236049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,7843,77,0.85 [0.48-1.50],0.573593703614981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,7783,80,1.04 [0.70-1.52],0.8586426597987112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,9252,88,1.65 [1.02-2.68],0.0420268127136563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,9151,89,0.89 [0.73-1.10],0.285817406371661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,8023,82,0.82 [0.49-1.40],0.4716867844674932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,7802,75,1.01 [0.55-1.84],0.9782380885950096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,8035,82,1.16 [0.88-1.51],0.2895013259532203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,8996,83,1.36 [0.79-2.35],0.2667514737774757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,7871,79,1.03 [0.49-2.15],0.9390300182209612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,7830,79,0.73 [0.40-1.33],0.3005828020925531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,8046,81,0.90 [0.71-1.14],0.3840312920699437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,8011,80,0.80 [0.35-1.82],0.5982824511902888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,7921,80,1.10 [0.60-2.01],0.7639718730500099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,9215,85,1.34 [0.72-2.48],0.3511824690981128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,8035,82,1.17 [0.65-2.09],0.6016784916715578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,9171,88,1.08 [0.55-2.14],0.8234345303023404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,9096,87,1.36 [0.73-2.56],0.3347460559460445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,7841,81,0.77 [0.50-1.18],0.2303903344442096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,9168,87,0.92 [0.76-1.10],0.3432273216775418
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,8972,86,0.95 [0.59-1.52],0.8219303361394867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,8011,80,0.45 [0.21-0.96],0.039351939090254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,9282,86,0.34 [0.11-1.08],0.0663455880096022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,9151,89,0.88 [0.61-1.28],0.5093569955684416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,8046,81,0.85 [0.63-1.14],0.276318637520873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,7871,79,0.95 [0.79-1.15],0.6073969233799404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",8042,80,0.83 [0.53-1.29],0.3995102687744761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",7974,80,0.84 [0.68-1.03],0.0982786444271598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,7802,75,0.61 [0.41-0.90],0.0123222109412798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,7871,79,1.13 [0.68-1.89],0.6297355055405326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,9110,87,1.07 [0.77-1.49],0.6856755215016501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,7830,79,1.02 [0.80-1.30],0.8604004296124743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,9173,88,1.01 [0.76-1.36],0.9263391326533256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,9266,87,0.98 [0.81-1.19],0.8371796077604703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,8035,82,0.82 [0.59-1.15],0.257167918239549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,7802,75,1.04 [0.63-1.70],0.8837570099648902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,9008,86,1.01 [0.50-2.03],0.9803620692496644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,8035,82,0.97 [0.75-1.24],0.798196617126148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,7783,80,0.94 [0.72-1.23],0.6474336686979771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELN,Elastin,8046,81,0.80 [0.44-1.45],0.465734525490824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,9137,86,0.93 [0.63-1.35],0.6897115716561313
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,7802,75,1.16 [0.70-1.92],0.5713233866104217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,9008,86,1.19 [0.80-1.76],0.3937776787907757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,7419,77,0.95 [0.61-1.48],0.8188806509666713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,9282,86,0.59 [0.19-1.79],0.3487388134079964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,9162,86,0.93 [0.73-1.18],0.5426565010420634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,9245,88,0.93 [0.69-1.25],0.6274694246361265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,7871,79,1.27 [0.89-1.79],0.18332224391247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,8023,82,1.21 [0.94-1.57],0.1444045632049768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,7802,75,0.85 [0.37-1.96],0.7086927778242096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,7802,75,1.15 [0.77-1.72],0.5073263470827949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,9282,86,1.49 [0.78-2.81],0.2254006721572161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,9220,88,1.12 [0.69-1.82],0.641201004541465
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,7871,79,1.46 [0.81-2.63],0.2056438607894053
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,8870,87,1.03 [0.82-1.28],0.8054438213716415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,8023,82,0.88 [0.57-1.35],0.5538677218556448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,8972,86,1.22 [0.79-1.86],0.3687685455280907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,8996,83,0.73 [0.29-1.84],0.4989116224822594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,8996,83,1.00 [0.49-2.02],0.9907095978822432
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,7871,79,0.75 [0.49-1.15],0.1824920387532576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,7830,79,0.82 [0.40-1.69],0.5928979843019322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,7841,81,0.75 [0.50-1.13],0.1752777296283198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,9173,87,0.69 [0.57-0.85],0.0003158732415168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,8023,82,0.89 [0.52-1.51],0.6642110164460879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,9214,88,1.74 [0.99-3.06],0.0540157016487974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,8948,82,0.94 [0.68-1.28],0.6786625498736321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,8847,84,1.48 [0.84-2.60],0.1780381424479502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,7902,78,0.65 [0.30-1.40],0.2741610993504455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,9282,86,1.70 [0.81-3.55],0.1585456111605549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,9091,87,1.78 [0.99-3.20],0.0560546227379768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,8996,83,0.98 [0.72-1.34],0.9188556340406384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,7921,80,1.21 [0.80-1.83],0.35690279820255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,9151,89,1.14 [0.90-1.46],0.2765217682581621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,7871,79,1.07 [0.80-1.44],0.6494506402695825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,9237,88,1.31 [0.70-2.45],0.392302192236884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,9214,89,1.44 [0.64-3.23],0.3800273977646869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,9166,88,1.12 [0.40-3.10],0.8267929230093266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,9214,89,1.37 [0.63-2.98],0.4313450111960631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,9137,86,1.01 [0.83-1.21],0.9562384512681232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,7841,81,0.92 [0.68-1.26],0.6077393505544346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,7775,79,0.93 [0.46-1.89],0.8460290644510223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,9091,87,1.07 [0.84-1.35],0.5945114156399511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,7921,80,0.75 [0.38-1.47],0.3960831085229409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,7830,79,0.61 [0.37-1.01],0.053835998159787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,8023,82,1.10 [0.65-1.88],0.718334915899072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,7902,78,0.99 [0.82-1.20],0.9369725782527554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,9116,86,1.71 [0.82-3.58],0.152588142541708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,7802,75,1.19 [0.75-1.91],0.4620380934441949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,9282,86,1.10 [0.60-2.01],0.766194435986059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,9173,88,1.16 [0.67-2.00],0.6064697112092334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,7775,79,1.31 [1.01-1.71],0.0446457272093727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,7830,79,0.95 [0.63-1.42],0.7945578588206168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,8042,80,1.03 [0.79-1.33],0.8537784243333153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,7775,79,1.44 [1.00-2.08],0.0509418556285452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,7830,79,0.86 [0.67-1.10],0.2192551694491122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,7921,80,0.79 [0.40-1.57],0.5030533862632651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,7802,75,0.89 [0.59-1.34],0.5896146607139716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,7802,75,1.31 [0.89-1.94],0.1715635986416952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,9245,88,1.97 [0.93-4.15],0.075062030939847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,8052,80,0.65 [0.30-1.42],0.2802891941303259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,7945,77,0.64 [0.29-1.44],0.2848115040439676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,9182,88,0.99 [0.70-1.39],0.9472485744316966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,8065,80,1.29 [0.77-2.15],0.3406279566998492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,8014,79,0.47 [0.21-1.08],0.075562814894955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,8065,80,1.53 [0.37-6.32],0.5582675391844811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,9202,88,0.96 [0.69-1.35],0.8215363935712665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,9201,86,0.54 [0.27-1.10],0.0884654099720224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,9215,85,1.32 [0.68-2.56],0.4080544509894448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,9205,85,1.64 [0.56-4.78],0.3631415358981369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",9173,88,1.02 [0.83-1.25],0.8750171316391965
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",9173,88,0.82 [0.63-1.06],0.1276689782982535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",8046,81,0.88 [0.56-1.38],0.5732170735662074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",9282,86,1.10 [0.76-1.61],0.6087963602245812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,9214,88,0.90 [0.68-1.19],0.4673696076654509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,8980,83,0.77 [0.53-1.11],0.1584370882432336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,9151,89,1.45 [1.05-2.01],0.0248797288290319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,9173,88,1.01 [0.79-1.30],0.9175417839846371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,8011,80,0.86 [0.62-1.20],0.3828786255365719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,8035,82,1.14 [1.02-1.28],0.0195687047597645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,8023,82,0.90 [0.40-2.04],0.7951925422174654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,7871,79,0.89 [0.62-1.27],0.5083107300258174
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,8046,81,1.74 [0.89-3.43],0.1076081011816285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,9137,86,0.77 [0.45-1.33],0.3550200220110318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,9157,88,1.46 [0.79-2.72],0.2304851493229909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,8011,80,1.03 [0.79-1.33],0.8401106968375434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,9282,86,0.93 [0.45-1.90],0.8369517998106323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,7841,81,0.93 [0.67-1.28],0.6521807786228027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,9264,86,1.21 [0.73-2.01],0.4519261493293804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,9266,87,0.97 [0.58-1.62],0.9014544862935248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,8062,80,1.10 [0.56-2.15],0.7921637216604527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,7841,81,1.18 [0.82-1.70],0.3770904618670271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",9173,88,0.98 [0.76-1.27],0.8729771257343972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,8046,81,1.08 [0.81-1.44],0.6071415373101798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,9151,89,1.06 [0.72-1.56],0.7716952955873787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,8035,82,0.60 [0.26-1.42],0.2474328964382245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,9182,88,1.41 [0.96-2.09],0.0807341321826368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,9153,85,0.79 [0.61-1.02],0.0657188763805635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,8972,86,0.95 [0.68-1.33],0.7607013770485975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,9200,85,0.86 [0.59-1.25],0.4295687382615571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,8032,80,0.95 [0.66-1.38],0.806376014997436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,9141,85,0.73 [0.47-1.12],0.1524983335550269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,9173,88,1.14 [0.75-1.75],0.5381525335727135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,9222,87,1.26 [0.87-1.83],0.2204202103445679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,9008,86,0.90 [0.64-1.27],0.5370039048257838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,9182,88,0.96 [0.69-1.35],0.8295050954327443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,9151,89,1.02 [0.78-1.34],0.8829527874473986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,8972,86,1.19 [0.89-1.58],0.2364996370008647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",7802,75,0.76 [0.50-1.15],0.1916721500095848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",7802,75,0.80 [0.51-1.23],0.3017725911506776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,8972,86,1.13 [0.88-1.46],0.3322043241756343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,8972,86,1.17 [0.81-1.71],0.4034794723308973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,9205,85,1.29 [0.70-2.39],0.4120369954021889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,7874,75,0.70 [0.34-1.46],0.3432229333833035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",8035,82,0.96 [0.73-1.25],0.7497389067241451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,7830,79,0.99 [0.62-1.60],0.9730298839406826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,7830,79,1.07 [0.70-1.63],0.7555345559933779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,9220,88,0.97 [0.76-1.25],0.8297468516380578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,9151,89,0.84 [0.63-1.13],0.247936033060982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,7830,79,0.84 [0.50-1.43],0.529880196002503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,9234,88,1.12 [0.95-1.31],0.17300945465324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,9239,88,1.03 [0.73-1.46],0.8673056819283378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,7830,79,0.62 [0.26-1.51],0.2919504605781803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,9008,86,0.76 [0.42-1.41],0.3883711043506539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,7830,79,0.53 [0.26-1.08],0.0806688161487026
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,7775,79,0.76 [0.54-1.08],0.1283415048684225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,7760,79,0.91 [0.54-1.52],0.7170268380760703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,9214,89,0.83 [0.46-1.51],0.5419043774373933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,8062,80,0.80 [0.52-1.23],0.3083124523036802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,8042,80,0.94 [0.52-1.69],0.8240394072287316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,9214,89,3.42 [1.58-7.40],0.0018396706703072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,7902,78,0.89 [0.59-1.34],0.5913093955217011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,8052,80,0.88 [0.64-1.21],0.4357008757908643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,8948,82,0.94 [0.66-1.34],0.7207752556035993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",7783,80,1.25 [1.03-1.52],0.0221180276127701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,7802,75,0.94 [0.58-1.52],0.7949158021274795
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,8948,82,0.97 [0.74-1.26],0.8082966255616889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,9196,88,0.95 [0.74-1.21],0.6620339347191111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,8035,82,0.97 [0.78-1.20],0.7806042913490858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,9195,86,1.03 [0.87-1.23],0.7088918564714903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,9110,87,1.13 [0.74-1.74],0.572590418441246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,9110,87,0.99 [0.81-1.22],0.9518375242027564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,8929,82,1.01 [0.66-1.55],0.9655783072477748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,8011,80,0.94 [0.64-1.36],0.7274864362025195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,8972,86,1.03 [0.87-1.23],0.7320576755192634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,9110,87,1.35 [0.69-2.63],0.3762475236807242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,9125,86,0.84 [0.33-2.14],0.7097094426837868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,8972,86,0.47 [0.24-0.94],0.033059034712445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,9266,87,1.49 [0.83-2.68],0.1827372621087807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,9214,89,0.50 [0.29-0.86],0.01226220282359
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,8948,82,0.94 [0.67-1.30],0.6914010346692951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,8972,86,0.96 [0.55-1.68],0.8968535864684041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,8065,80,1.22 [0.54-2.75],0.6276838339823957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,8042,80,1.48 [0.92-2.38],0.1035642592558707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,8023,82,0.89 [0.47-1.68],0.7171045581666633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,7830,79,0.84 [0.63-1.12],0.237708336734582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,9177,89,2.67 [1.46-4.86],0.0013905395603941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,9245,88,2.34 [1.28-4.28],0.0058797843168606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,9185,89,0.98 [0.88-1.09],0.680779953112545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,7760,79,0.75 [0.41-1.38],0.3585087146470331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,8948,82,1.34 [0.92-1.95],0.124432372938707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,7830,79,0.78 [0.45-1.34],0.3624609378665483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,9151,89,0.93 [0.74-1.17],0.5393638133512371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,8972,86,1.13 [0.93-1.37],0.2298219336473397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,7802,75,0.81 [0.57-1.13],0.2180948910725511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,7841,81,0.87 [0.45-1.68],0.6790361651642804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,9080,87,0.99 [0.47-2.10],0.9758943437398389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,7871,79,0.94 [0.66-1.33],0.7160663919153614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FST,Follistatin,9202,88,1.18 [0.82-1.71],0.3758554922375076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,7871,79,1.00 [0.38-2.61],0.9948605954947396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,9161,88,1.31 [0.73-2.34],0.3622917100909858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,8028,80,1.15 [0.90-1.47],0.2544829133573169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,9241,86,0.85 [0.69-1.05],0.1408329672605887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,7902,78,0.81 [0.57-1.14],0.2172642320748641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FURIN,Furin,9214,89,1.68 [0.96-2.94],0.069063044153285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,8960,86,1.04 [0.64-1.69],0.8734777569955865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",7900,80,0.96 [0.68-1.36],0.8207866673546599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,9245,88,0.88 [0.58-1.31],0.5204937056273529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",9110,87,0.91 [0.66-1.26],0.5684962058502427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",9252,88,1.03 [0.80-1.33],0.8025396092732313
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,9008,86,0.95 [0.70-1.28],0.7173506289816308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,9168,88,0.93 [0.76-1.14],0.4880435477014563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,7841,81,1.43 [1.14-1.80],0.002308929865909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,7783,80,0.85 [0.50-1.46],0.5606507769925291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,8023,82,1.08 [0.73-1.60],0.7035273903456007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,7921,80,1.20 [0.92-1.57],0.1768655846503207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,7783,80,0.91 [0.63-1.31],0.5993636426379096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,7775,79,1.43 [0.62-3.26],0.39940205871966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,7830,79,0.59 [0.32-1.08],0.0874258660547215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,7921,80,0.81 [0.48-1.35],0.414186101937976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,7871,79,0.99 [0.65-1.50],0.9686698158444318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,7775,79,0.98 [0.69-1.38],0.8874533285837654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,9220,88,1.02 [0.75-1.39],0.8852099579661061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,9137,86,1.24 [0.61-2.51],0.5490694762576247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,9252,88,1.36 [0.67-2.78],0.3916098086627215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,9008,86,0.98 [0.62-1.55],0.925244251390382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,8046,81,1.77 [0.92-3.42],0.087185177300175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,9137,86,1.12 [0.45-2.81],0.8098345960233673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,7802,75,0.86 [0.46-1.61],0.630116153750973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,7732,77,1.12 [0.57-2.21],0.7385010848571092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,8035,82,1.21 [0.60-2.47],0.591802006482364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,7921,80,0.80 [0.49-1.31],0.3811858032821646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,9234,86,1.18 [0.56-2.53],0.6616288386488882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,7802,75,1.04 [0.62-1.74],0.881536534154391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,8042,80,1.17 [1.03-1.33],0.01955491758282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,7775,79,1.09 [0.49-2.42],0.8327052825070833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",7871,79,1.00 [0.75-1.33],0.98671411243246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,7841,81,0.85 [0.57-1.28],0.4490890335603206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,8028,80,1.23 [0.90-1.68],0.1999310765760309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,9008,86,1.04 [0.75-1.43],0.8307209521314551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,8948,82,0.68 [0.44-1.04],0.0779665829603729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,7802,75,0.66 [0.36-1.23],0.1931744474038659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,8065,80,1.05 [0.46-2.38],0.9107575306313156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,8042,80,0.95 [0.78-1.17],0.6391607753544045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,8972,86,1.14 [0.98-1.33],0.0835825123167217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,7722,76,1.06 [0.68-1.64],0.8054409596587279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,7802,75,0.69 [0.40-1.21],0.1991169587509536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",9137,86,0.79 [0.45-1.38],0.4084267404290145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,9282,86,1.40 [0.93-2.11],0.1078480387752307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,9173,88,1.94 [1.16-3.24],0.0112947528680297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,8948,82,1.33 [0.82-2.18],0.248065779974324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,8046,81,0.96 [0.65-1.42],0.8418524203387381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,8952,86,0.86 [0.58-1.27],0.43841626113993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,8972,86,0.93 [0.68-1.27],0.6641299969664094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,8972,86,1.02 [0.87-1.18],0.8432705564391068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,9234,88,1.15 [0.59-2.23],0.6830698751187307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,9137,86,1.11 [0.46-2.70],0.8204008786477951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,9085,86,1.24 [0.64-2.40],0.5237808128473292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,7799,78,1.01 [0.71-1.44],0.9671205277815264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,8948,82,1.12 [0.86-1.48],0.3998131247416925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,8046,81,0.95 [0.70-1.29],0.7513008922027807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,8024,81,0.96 [0.61-1.50],0.8614810730616824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,9050,83,0.75 [0.42-1.35],0.3400714546285832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,9171,88,1.18 [0.82-1.71],0.3741348030246242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,9110,87,0.90 [0.38-2.13],0.8177631990251267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,9157,88,1.04 [0.93-1.16],0.4761341092772357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,8972,86,0.91 [0.80-1.03],0.1416806265332309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,7902,78,0.96 [0.44-2.09],0.9144402415094236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,8948,82,0.94 [0.64-1.36],0.7295939230938591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,9173,88,1.01 [0.81-1.27],0.9088126147116355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,8035,82,0.89 [0.44-1.79],0.7451799345352224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,8035,82,0.95 [0.71-1.26],0.7018343713170461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,7902,78,0.64 [0.31-1.34],0.2396637808820872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,7775,79,0.74 [0.47-1.19],0.217565293857109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,7871,79,0.95 [0.66-1.37],0.802934130160432
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,8042,80,0.85 [0.41-1.78],0.6735062044512973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,8011,80,0.91 [0.73-1.13],0.382328074530075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,7830,79,0.42 [0.23-0.77],0.0045359301794029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,7830,79,0.91 [0.73-1.15],0.4267254099129731
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,7775,79,0.80 [0.54-1.18],0.2551437881785759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,8778,79,1.18 [0.56-2.46],0.6656749194696407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,7888,78,1.18 [0.66-2.14],0.5748319173100962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,9110,87,1.02 [0.63-1.64],0.9394502629539264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,7830,79,1.04 [0.53-2.06],0.9077177707552848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,8996,83,1.09 [0.79-1.51],0.5895585090576192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,9178,88,0.77 [0.45-1.30],0.3230763319878502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,7783,80,0.99 [0.56-1.77],0.9810655119343972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,9100,88,0.87 [0.62-1.21],0.4037464919085033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",7902,78,1.02 [0.80-1.31],0.8702868742134051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,8948,82,0.83 [0.51-1.33],0.4378343851434596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,8023,82,1.44 [1.13-1.84],0.0033257956632953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,7851,79,0.93 [0.53-1.62],0.7860319518127198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,8046,81,0.93 [0.69-1.26],0.6361947873579852
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,9266,87,1.14 [0.78-1.66],0.5058054883586596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,7902,78,1.10 [0.80-1.51],0.5660528307420533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,8035,82,0.79 [0.59-1.05],0.1033462818840632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,8972,86,1.03 [0.77-1.38],0.8608260154762462
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,7841,81,1.05 [0.71-1.55],0.7999255563158846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,9182,88,0.74 [0.51-1.07],0.1071786263346458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,7871,79,0.66 [0.30-1.43],0.2921102127027976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,7902,78,0.91 [0.49-1.67],0.7522576924231845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,8035,82,1.27 [0.98-1.64],0.0717038584879739
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,9245,88,3.07 [1.58-5.97],0.0009399810296429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,9151,89,0.94 [0.78-1.13],0.4805610623720346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,8011,80,0.88 [0.55-1.41],0.5967286733169648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",8062,80,0.86 [0.49-1.50],0.5918930437347052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,9134,84,0.83 [0.45-1.53],0.5564123389094267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,7802,75,0.78 [0.56-1.10],0.1572561162294094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,8895,83,1.18 [0.96-1.46],0.1109751914615458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,7902,78,0.65 [0.36-1.16],0.1406787742181494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,9168,88,0.92 [0.74-1.14],0.4266510808672324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,9137,86,0.80 [0.70-0.92],0.0018027186522667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,9252,88,1.32 [0.69-2.50],0.3981771263834224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,9110,87,0.78 [0.56-1.10],0.1549910009674215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,8023,82,1.24 [0.83-1.84],0.2899429130149319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,8011,80,0.94 [0.59-1.52],0.8147389489560325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,8052,80,1.04 [0.66-1.64],0.8711962647253576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,8011,80,1.33 [0.96-1.85],0.0872673960168195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,8948,82,1.32 [0.74-2.36],0.3422516600705274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,8918,87,0.83 [0.42-1.64],0.5958283670352269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,7783,80,1.17 [0.87-1.59],0.2957328060695803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,8035,82,0.99 [0.54-1.80],0.9753180594981864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,8011,80,0.89 [0.62-1.28],0.5365715151688486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,8996,83,1.33 [1.00-1.77],0.0536899637447474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,8023,82,1.24 [0.88-1.73],0.2153895048609405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,9173,88,0.97 [0.84-1.13],0.7261253664278591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,8046,81,0.94 [0.67-1.31],0.7174483695898598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",8035,82,0.74 [0.43-1.27],0.2741654896449859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",7783,80,0.96 [0.65-1.43],0.858721168418048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,8996,83,0.66 [0.41-1.05],0.0815043212476658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,9148,88,1.10 [0.49-2.44],0.8207228281597975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,7871,79,1.33 [0.91-1.94],0.1406985573819911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",9137,86,1.33 [0.99-1.79],0.0627282468141939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,7729,79,1.09 [0.83-1.41],0.5380246364354995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,8972,86,1.02 [0.83-1.27],0.8216164746235433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,8027,80,1.53 [0.51-4.61],0.4529966399691368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",8007,80,0.72 [0.31-1.68],0.4453707196820632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,9156,88,1.05 [0.83-1.31],0.6993754018884573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,8972,86,0.92 [0.71-1.19],0.5364792189887684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,7802,75,0.97 [0.71-1.33],0.8589800884543755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,8893,81,1.06 [0.80-1.40],0.7004812933454123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,8042,80,1.00 [0.91-1.09],0.9963829167384706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,7921,80,0.91 [0.65-1.27],0.5877089168885905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,7841,81,0.86 [0.66-1.14],0.2951947797688536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,9137,88,1.18 [0.67-2.07],0.5587005915127873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,7921,80,1.02 [0.79-1.31],0.893494295529494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,7802,75,1.11 [0.62-1.97],0.7265357036576974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,9234,86,1.08 [0.79-1.48],0.6119313855949469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",8996,83,1.06 [0.86-1.31],0.5942077232652514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,9266,87,0.83 [0.48-1.43],0.50333719091644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,9151,89,0.92 [0.68-1.25],0.6036762129194817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,8996,83,0.98 [0.76-1.27],0.9037415255036818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,7775,79,1.42 [1.11-1.81],0.0049220837866775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",7802,75,0.87 [0.60-1.28],0.4947657407034596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",9217,88,0.99 [0.77-1.28],0.9455997818827048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,9252,88,1.03 [0.89-1.19],0.7085775684694557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",9182,88,0.98 [0.77-1.25],0.8663098266794319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,9235,88,1.13 [0.84-1.52],0.4265457277190267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,9182,88,1.56 [0.93-2.62],0.0915258072577792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,9217,88,0.97 [0.75-1.26],0.8092094190407586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,9252,88,0.90 [0.66-1.24],0.5181113827734212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,8046,81,1.01 [0.82-1.23],0.9534336860389891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,7802,75,1.03 [0.71-1.50],0.8781389423335697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,9266,87,1.00 [0.71-1.42],0.9960959560157236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,7830,79,0.77 [0.48-1.24],0.2791760717056653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,7783,80,0.80 [0.53-1.21],0.2973362870856575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,8011,80,0.83 [0.50-1.36],0.4513665875624929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,9239,88,1.15 [0.95-1.40],0.1510559539104447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,8042,80,1.02 [0.72-1.43],0.9259588348783786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,8996,83,0.92 [0.64-1.34],0.676836094444889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,7902,78,0.53 [0.23-1.21],0.131346377850873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,8042,80,0.90 [0.53-1.51],0.6806047843716768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,8046,81,1.06 [0.45-2.49],0.8995490949317364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,9151,89,0.95 [0.75-1.20],0.651634256965963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,9266,87,1.38 [0.81-2.36],0.2416910498502887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,7969,78,0.92 [0.45-1.87],0.8173966212263001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,8972,86,0.94 [0.74-1.21],0.649218744725232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,8042,80,1.04 [0.78-1.38],0.8056016133692131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,7830,79,1.15 [0.87-1.53],0.3227456501389011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,7802,75,0.86 [0.41-1.79],0.688254772778631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,8023,80,1.01 [0.61-1.69],0.9661841041606084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,8035,82,1.35 [0.95-1.92],0.0971173760098891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,8996,83,1.22 [0.63-2.37],0.5634147525138746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",8035,82,0.99 [0.52-1.89],0.9696414035025904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",9128,89,0.93 [0.56-1.56],0.7883894667698492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",9151,89,1.30 [0.70-2.41],0.4097043440402813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,9252,88,0.91 [0.60-1.38],0.6627459164798517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,7889,78,0.83 [0.57-1.22],0.3441627667976822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",7871,79,0.92 [0.58-1.45],0.7156952473501492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",7802,75,1.03 [0.62-1.71],0.9000549290721355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,7761,79,1.06 [0.70-1.60],0.7870308149902128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,9073,88,0.94 [0.62-1.41],0.7568323186260038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,8948,82,1.10 [0.72-1.69],0.6437908594705215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,7841,81,1.10 [0.84-1.44],0.4807149450383188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,9064,87,1.05 [0.70-1.58],0.8042830046996554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,8975,83,0.98 [0.76-1.27],0.9008526969255696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,8035,82,0.87 [0.55-1.40],0.5778886791936817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,9266,87,1.02 [0.79-1.33],0.8652833461788748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,8972,86,1.18 [0.71-1.96],0.5311476481719853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,7950,78,0.89 [0.70-1.12],0.3120946951061253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,7901,80,0.84 [0.63-1.11],0.2165869250606505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,7871,79,0.71 [0.37-1.39],0.3236596792526969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,8014,79,0.59 [0.30-1.16],0.1276255445668906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,7871,79,0.91 [0.70-1.16],0.4366089562876645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,9137,86,1.11 [0.67-1.83],0.6790344605924765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,9252,88,1.29 [0.75-2.22],0.3570752010136049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,7830,79,1.02 [0.51-2.05],0.954946644741749
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,7871,79,1.06 [0.85-1.33],0.6119526872034547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,9151,89,0.94 [0.58-1.51],0.7975031835222304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,8042,80,0.68 [0.48-0.95],0.0236024414857679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,7802,75,0.85 [0.53-1.38],0.5194225922063762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,7871,79,1.22 [0.79-1.90],0.3694074329863658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,8907,82,0.94 [0.69-1.29],0.7160599354557828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,9214,88,1.00 [0.77-1.31],0.9757950727441425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,8023,82,0.60 [0.29-1.23],0.1602601736267437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,9038,87,0.91 [0.69-1.20],0.5146578141468499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,9252,88,1.38 [0.84-2.27],0.2053512522927125
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,9126,85,1.47 [0.72-3.00],0.288061811171291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,7783,80,1.00 [0.77-1.29],0.975289812333282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,7783,80,0.72 [0.40-1.29],0.2677351378976532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",9214,89,0.96 [0.71-1.31],0.8135435553205791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,9132,83,0.70 [0.29-1.66],0.4173713493457756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,9282,86,1.80 [0.76-4.23],0.1799494970887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,9008,86,0.96 [0.75-1.23],0.7253213660477147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,9145,85,0.88 [0.44-1.76],0.717102909668355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,9282,86,0.39 [0.22-0.68],0.001042198199946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,9282,86,0.86 [0.41-1.84],0.7026722858144535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,9151,89,0.86 [0.60-1.22],0.38979648894142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,9173,88,1.01 [0.66-1.54],0.9780440944771264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,9137,86,1.21 [0.45-3.25],0.7127056795668474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,7921,80,0.76 [0.42-1.36],0.3538280764449804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,8948,82,1.01 [0.66-1.55],0.957322015709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",7871,79,0.99 [0.71-1.38],0.9503092980717548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,9266,87,1.88 [0.18-19.23],0.5934556721224564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,9252,88,1.11 [0.73-1.69],0.6339797011357038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,7798,75,1.30 [0.75-2.27],0.3453199894159159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,7921,80,0.95 [0.63-1.44],0.8171008144112217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,7921,80,1.03 [0.59-1.81],0.9157623415779584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,8011,80,0.85 [0.36-1.99],0.7095135993046484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,9008,86,1.00 [0.84-1.18],0.9580402649090416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,9220,88,1.66 [0.67-4.09],0.2703595368545649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,9110,87,1.42 [1.01-2.00],0.0447923298772894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,8948,82,1.41 [0.95-2.10],0.0896133616223794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,7783,80,1.09 [0.80-1.48],0.5951700921055646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,9151,89,1.00 [0.59-1.68],0.9859079943158586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,7802,75,0.86 [0.44-1.68],0.6608484842656719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,7841,81,1.00 [0.61-1.65],0.9896634339011108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,8035,82,1.11 [0.79-1.56],0.5579384305923772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,7783,80,0.73 [0.42-1.28],0.2738752016926008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,8062,80,0.86 [0.37-1.99],0.7307470980468351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,9137,86,0.49 [0.19-1.26],0.1404511314748066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,7802,75,1.17 [0.76-1.79],0.4701445652028726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,9182,88,1.69 [0.73-3.90],0.2174721688456651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,9268,86,1.02 [0.86-1.20],0.822815872944217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,9271,86,0.93 [0.69-1.27],0.6500927838891011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,9224,85,0.97 [0.49-1.91],0.9244752562743151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,9074,86,1.26 [0.82-1.94],0.2901547038972454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,9148,85,1.47 [0.79-2.76],0.227755822280098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,9282,86,1.31 [0.70-2.47],0.3993258296121945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,9173,88,2.00 [1.20-3.33],0.0078403989948026
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,7830,79,0.98 [0.73-1.32],0.8903321735128753
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,7802,75,0.85 [0.55-1.32],0.4751372384028254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,8045,80,0.82 [0.32-2.08],0.6795666422801006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,7775,79,1.06 [0.86-1.30],0.5823362210985722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,7871,79,0.86 [0.47-1.58],0.6364928101573455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,9137,86,1.18 [0.66-2.10],0.573121272336822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,9173,88,1.17 [0.62-2.21],0.633347131089379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,8046,81,1.33 [1.04-1.71],0.0256591652594573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,9151,89,0.88 [0.72-1.09],0.2528687044902072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,8972,86,0.92 [0.72-1.17],0.4900683578242354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,9008,86,1.20 [1.00-1.44],0.0527067755854421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,9008,86,0.94 [0.66-1.33],0.7237030962128166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,9220,88,2.14 [1.22-3.78],0.0084448182258187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,9008,86,1.00 [0.75-1.35],0.9892355306671404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,9137,86,0.96 [0.75-1.22],0.7216854811407185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,9266,87,1.07 [0.76-1.51],0.6963432002486518
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,9008,86,1.41 [0.87-2.31],0.1668891800120836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,7830,79,1.15 [0.70-1.91],0.5821845096255165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,9008,86,1.17 [0.85-1.62],0.3305367005214136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,9071,88,1.23 [0.49-3.12],0.6588387966798412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,7783,80,1.65 [0.83-3.28],0.1566138408582598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,9151,89,1.66 [0.97-2.85],0.0627504448669488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,9008,86,1.92 [1.12-3.28],0.0180663906220276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,9266,87,1.25 [0.82-1.92],0.2963020115820427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,8999,86,1.01 [0.66-1.56],0.9541917324896676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,9008,86,1.18 [0.93-1.49],0.1691448406204067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,9008,86,0.65 [0.33-1.28],0.2152030057102507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,9008,86,1.11 [0.90-1.38],0.3260610770406718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,9182,88,1.02 [0.67-1.57],0.9218275868136708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,9037,89,0.91 [0.63-1.31],0.6228902673924168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,9147,88,1.08 [0.74-1.59],0.6894935261064353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,9224,85,1.68 [0.95-2.97],0.0743385021099197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,9266,87,1.92 [1.10-3.34],0.0210040516032326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,9050,87,1.07 [0.97-1.18],0.1885637147930846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,8944,86,1.28 [0.99-1.66],0.0571477346895338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,9008,86,1.20 [0.92-1.57],0.1706101344934473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,8968,85,1.03 [0.74-1.44],0.8647377715786879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,9171,88,1.35 [0.59-3.10],0.4796294397631647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,9164,88,1.80 [0.67-4.83],0.2404630575482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,9182,88,0.84 [0.54-1.31],0.4497167215297433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,9264,86,1.48 [0.96-2.27],0.0744366667739925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,9008,86,1.04 [0.63-1.71],0.8895182330016724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,9176,88,0.90 [0.64-1.29],0.5753522705325149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,9008,86,1.68 [0.91-3.09],0.0978059062663545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,9008,86,1.10 [0.79-1.52],0.5776644550844632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,9008,86,0.95 [0.62-1.47],0.8304722610887716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,7830,79,0.80 [0.46-1.39],0.4323677229439291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,7830,79,0.91 [0.59-1.39],0.6505594483698034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,8023,82,1.04 [0.76-1.40],0.8214381843594998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,9008,86,1.17 [0.79-1.73],0.4373718951801932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,9008,86,1.04 [0.72-1.51],0.8365807585063736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,7746,79,0.87 [0.47-1.63],0.6690224435474202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,9105,83,1.45 [0.92-2.28],0.1134441880036631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,9008,86,1.08 [0.70-1.69],0.718425203091546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,8023,82,1.10 [0.66-1.83],0.7111208919342605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,7775,79,0.97 [0.67-1.39],0.8658657931592747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,7830,79,1.04 [0.71-1.52],0.8416130962904615
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,7796,79,1.00 [0.58-1.74],0.9881779207967616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,9151,89,0.62 [0.39-0.99],0.0455002943371159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,9008,86,1.14 [0.69-1.87],0.6173128241463708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,8937,82,1.21 [0.70-2.11],0.49738894058032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,7830,79,1.02 [0.70-1.49],0.9126258265540528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,7790,79,0.86 [0.60-1.23],0.4048483088106007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,9008,86,0.90 [0.49-1.63],0.7187823548014909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,9008,86,0.90 [0.75-1.08],0.2546763820562323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,9151,89,1.09 [0.65-1.83],0.7520839780495019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,9008,86,0.99 [0.86-1.14],0.8972867648055474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,9151,89,0.82 [0.58-1.17],0.2757829827110665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,9137,86,1.03 [0.80-1.32],0.8269590592681476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,9130,85,1.36 [0.77-2.41],0.2851143722893551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,9173,88,0.64 [0.21-1.97],0.4368208954995247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,9151,89,0.92 [0.68-1.24],0.5785308698394613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,9182,88,1.02 [0.71-1.46],0.9162159576455142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,7921,80,0.97 [0.66-1.44],0.8950104724239519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,8938,82,0.89 [0.62-1.28],0.527295719464941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,8023,82,1.05 [0.65-1.70],0.8548453535250498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,9110,87,0.89 [0.64-1.22],0.461017526499177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,8042,80,0.89 [0.61-1.31],0.5587617309678967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,7783,80,0.95 [0.45-2.00],0.8840110739638741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,8929,82,0.68 [0.42-1.12],0.1286452257428068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,7902,78,0.86 [0.57-1.31],0.4920444530733058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,9182,88,0.90 [0.58-1.40],0.6474810728798415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,9137,86,0.83 [0.57-1.19],0.3085895981202235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",7871,79,0.89 [0.60-1.32],0.554869512396696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",8035,82,1.31 [0.90-1.90],0.160634738497857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",9137,86,0.92 [0.76-1.13],0.4363384232363391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,8042,80,0.79 [0.57-1.09],0.1568045542864809
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,8023,82,0.78 [0.47-1.29],0.3257081296016641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,8011,80,1.10 [0.88-1.37],0.423174606097916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,7830,79,0.53 [0.14-1.95],0.3389032543789179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,9096,87,1.06 [0.85-1.31],0.6176119305021313
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,9137,86,0.78 [0.54-1.12],0.1753878359863192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",8996,83,0.80 [0.62-1.02],0.0725623863209578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,9008,86,0.96 [0.72-1.29],0.8043181662049317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,9151,89,0.96 [0.80-1.15],0.6316095992150823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,8831,81,0.56 [0.33-0.95],0.0319865467676308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,9151,89,1.62 [0.98-2.68],0.0611868316959293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,8062,80,0.73 [0.43-1.24],0.2376076233606864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,7948,80,0.97 [0.78-1.20],0.7621967709568436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,9151,89,0.74 [0.42-1.28],0.2783094362215993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,7902,78,0.61 [0.33-1.15],0.1259123197173182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,9182,88,1.10 [0.51-2.37],0.8045545797263975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,9151,89,1.09 [0.77-1.53],0.6375591194897836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,7830,79,1.24 [0.74-2.08],0.4136084511014977
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,9182,88,0.64 [0.35-1.19],0.1582328358982654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,9252,88,0.81 [0.25-2.64],0.7212695555509825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,7921,80,1.12 [0.77-1.61],0.5569936364605326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,9185,85,0.75 [0.30-1.89],0.54580637614658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,8972,86,1.01 [0.64-1.60],0.957398936500797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,8996,83,0.98 [0.82-1.16],0.7855785769437197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,9121,86,0.81 [0.41-1.62],0.5525324132848991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,9214,89,0.80 [0.47-1.35],0.4040896042646665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,9008,86,1.33 [0.70-2.54],0.3832749267870762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,9252,88,1.20 [0.81-1.80],0.3602414214474209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,8062,80,0.73 [0.39-1.38],0.3340300461559952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,8065,80,1.10 [0.36-3.40],0.8625542957374557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,9224,85,1.31 [0.78-2.21],0.3121497124015128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,8065,80,1.14 [0.52-2.53],0.7375894807910699
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,8023,82,1.03 [0.65-1.65],0.8933201982653324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,9151,89,1.18 [0.86-1.60],0.30544294715154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,7802,75,0.98 [0.71-1.37],0.9195838027258704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",7871,79,0.87 [0.62-1.22],0.411596706437805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",7783,80,1.43 [0.97-2.12],0.0707720091257956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",8948,82,1.22 [0.85-1.76],0.2821744673237384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,7775,79,0.69 [0.39-1.24],0.2161058061917523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,9245,88,1.79 [0.91-3.52],0.0915827829229557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,7902,78,0.94 [0.60-1.48],0.7949163228332767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,9008,86,0.81 [0.60-1.11],0.1898633496080055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,7775,79,1.30 [0.98-1.74],0.0731310605291199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,8011,80,0.88 [0.68-1.13],0.308556833575867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,9008,86,0.92 [0.61-1.40],0.7089599321968478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,9137,86,0.92 [0.60-1.39],0.6796669064735619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,8011,80,0.89 [0.72-1.09],0.256199601940427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,7783,80,1.18 [0.85-1.64],0.3319848220468122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,7841,81,0.76 [0.53-1.10],0.1420000435086921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,8948,82,1.06 [0.72-1.54],0.7756142727453882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,7900,80,1.11 [0.69-1.79],0.6790569781743059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,7830,79,0.84 [0.62-1.15],0.2834469304843183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,9214,89,0.59 [0.28-1.25],0.1672743581542501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,8948,82,0.74 [0.43-1.28],0.2814947119470448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,7775,79,0.73 [0.48-1.11],0.1413904288556603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,7871,79,0.99 [0.70-1.40],0.9573875806162536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,8042,80,0.81 [0.39-1.68],0.5717900922299071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,7921,80,0.82 [0.61-1.10],0.1830262822201467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,7921,80,1.68 [0.92-3.10],0.0937115072308985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,8023,82,0.85 [0.55-1.32],0.472028068891974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,7802,75,0.80 [0.39-1.64],0.5446306114306836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,7783,80,0.84 [0.62-1.14],0.2621014217089059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,7802,75,0.95 [0.80-1.14],0.6093451970961479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,9137,86,0.98 [0.78-1.23],0.8478484163421145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,8023,82,0.86 [0.68-1.09],0.2194330160899884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,8972,86,0.91 [0.71-1.16],0.4448235126030646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,8011,80,0.97 [0.85-1.09],0.588481752046794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,8972,86,0.99 [0.85-1.15],0.8727556777214935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,7775,79,1.12 [0.90-1.39],0.3311179422890966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,7783,80,0.91 [0.60-1.37],0.6460086283362422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,8948,82,1.33 [0.83-2.14],0.2414753465945503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,9205,85,0.46 [0.25-0.88],0.0186800743467479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,9173,88,0.80 [0.48-1.34],0.4010689787925952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,8948,82,0.87 [0.66-1.14],0.3134183880207284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,7783,80,0.68 [0.38-1.24],0.2082006858721599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,8035,82,1.10 [0.71-1.70],0.6743652591624127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,9081,89,1.13 [0.99-1.30],0.0745310503793453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,9180,89,1.27 [0.81-1.99],0.2929897427972317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,9128,88,1.26 [0.72-2.23],0.4186203315253743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,8972,86,1.00 [0.88-1.15],0.9497589509664895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,8972,83,0.75 [0.49-1.16],0.1948762797154681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,9252,88,1.31 [0.88-1.94],0.190289100867431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,8014,82,0.97 [0.65-1.46],0.8988993505632864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,8062,80,0.82 [0.56-1.19],0.2893150882189689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,9252,88,1.04 [0.76-1.43],0.7856326522828972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,9197,88,0.97 [0.53-1.78],0.9120267414621802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,7712,78,0.68 [0.38-1.23],0.2047484589626728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,8877,85,1.21 [0.71-2.05],0.477661266826961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,7889,76,1.16 [0.48-2.85],0.7381055904498506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,9266,87,1.16 [0.71-1.90],0.5497899279852196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,7783,80,0.99 [0.68-1.44],0.9696671744559516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,9266,87,0.81 [0.53-1.23],0.3208203058022273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,7830,79,1.06 [0.67-1.68],0.8011389271791615
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,8042,80,0.79 [0.51-1.23],0.2935669941159269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",8651,80,0.59 [0.27-1.32],0.1979308776333898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",7802,75,0.78 [0.42-1.47],0.4486626828207094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",9137,86,1.11 [0.87-1.40],0.4008054315034136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",9133,88,1.03 [0.78-1.36],0.8240938688428228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",8948,82,1.15 [0.77-1.71],0.4901204564927467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",7802,75,1.35 [0.82-2.20],0.2393929010142869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",7783,80,0.85 [0.58-1.24],0.3999746843777045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,9164,88,0.98 [0.70-1.37],0.9079216018072483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,9266,87,0.90 [0.59-1.39],0.6468743118344388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,9214,89,0.83 [0.43-1.61],0.5790039439862487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,8046,81,0.92 [0.73-1.17],0.5156775834119407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,8002,82,1.05 [0.72-1.54],0.7883688835127397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,9173,88,0.92 [0.68-1.23],0.5542932915104966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,9137,86,1.23 [0.78-1.94],0.3803815277686665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,9173,88,1.32 [0.83-2.09],0.2354122187930596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,9110,87,1.08 [0.89-1.30],0.4365934603722102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,7802,75,1.27 [0.92-1.75],0.1391785578207596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,9220,88,0.94 [0.52-1.69],0.838827804231983
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,7871,79,1.88 [0.89-3.94],0.0965962846937035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,7820,79,0.32 [0.11-0.93],0.0367729906149567
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,8899,86,1.61 [0.55-4.64],0.3825599921353813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,9253,87,1.13 [0.78-1.62],0.5207665200861717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,8023,82,0.99 [0.59-1.66],0.969490745628737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,9008,86,0.78 [0.51-1.19],0.2451443089849794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,8023,82,0.95 [0.67-1.36],0.7908260771514175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,9266,87,1.00 [0.78-1.28],0.9862376845793978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,9137,86,0.95 [0.81-1.11],0.5357843261623121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,7830,79,1.05 [0.81-1.37],0.7006488239355743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,9091,87,1.63 [0.98-2.70],0.0614881424067931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,9224,85,1.18 [0.85-1.64],0.3276504881849969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,9245,88,0.94 [0.70-1.26],0.6876771436909369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,8052,80,0.69 [0.32-1.51],0.3584220774191926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,8035,82,0.93 [0.65-1.33],0.6966233304342923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,8933,83,1.17 [0.72-1.90],0.5133854863974361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,8062,80,0.71 [0.44-1.16],0.1677979594400631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,9196,85,1.09 [0.76-1.57],0.6400440011388038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,8035,82,0.95 [0.76-1.18],0.6237681995309444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,8046,81,0.88 [0.64-1.22],0.4445049707588339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,9234,88,1.10 [0.74-1.64],0.6420193767408953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,7639,78,1.03 [0.75-1.42],0.8487277138727279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,7783,80,1.05 [0.79-1.39],0.7496666149465693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,8035,82,1.31 [0.88-1.96],0.1808215990523661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEP,Leptin,9173,88,0.97 [0.71-1.31],0.8225882715554833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,9173,88,0.58 [0.30-1.13],0.1102913248150387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,8035,82,1.10 [0.74-1.65],0.6284513873274443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,9173,88,1.33 [0.78-2.27],0.2913642413018967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,9194,86,1.58 [0.86-2.90],0.1396571855792252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,8065,80,1.48 [0.80-2.73],0.2132604433213381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,9173,88,0.88 [0.61-1.26],0.4828291809649596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,9150,88,1.16 [0.73-1.85],0.5238742447053713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,9245,88,0.84 [0.61-1.16],0.2883515870550572
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,9184,88,1.16 [0.65-2.06],0.6234969313903922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,9220,88,0.75 [0.44-1.28],0.2867746720660955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,8972,86,0.89 [0.68-1.15],0.3651647982955385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,9194,88,0.95 [0.69-1.31],0.7466452859450825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,8948,82,0.85 [0.56-1.29],0.4380260122746711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,9151,89,0.77 [0.35-1.69],0.5148586939080653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,9182,88,1.01 [0.59-1.73],0.9583987887040942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,8062,80,0.93 [0.82-1.05],0.2349770782592899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,7802,75,0.98 [0.63-1.53],0.9371526970809916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,9157,88,0.65 [0.36-1.17],0.1483415235215393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,8046,81,0.92 [0.70-1.23],0.5882756045116009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,9282,86,0.67 [0.33-1.33],0.2497758321662283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,9253,86,1.41 [0.80-2.48],0.2403795784653713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,9008,86,1.43 [0.94-2.17],0.0937626397857597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,9282,86,0.96 [0.74-1.25],0.7742077020999489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,7871,79,1.01 [0.71-1.44],0.9497811423526576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,7993,80,1.30 [0.97-1.73],0.0810990640878511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,8042,80,1.96 [1.00-3.85],0.0515936732216987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,8035,82,1.05 [0.59-1.86],0.8711361953183437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,7783,80,1.01 [0.71-1.43],0.9754354961024234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",7871,79,0.94 [0.73-1.22],0.6576781724863263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),7870,75,0.98 [0.87-1.12],0.8046058841854442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,9137,86,0.81 [0.46-1.44],0.4747966992492997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,9173,88,0.97 [0.64-1.45],0.8704924640088814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,8883,86,1.12 [0.82-1.54],0.4715942511186446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,7802,75,0.86 [0.60-1.22],0.3877501278297479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,7802,75,0.93 [0.66-1.31],0.6575081444963999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,7841,81,1.07 [0.70-1.64],0.7409968988033688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,8065,80,0.60 [0.27-1.33],0.209386991660299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,9217,88,1.52 [0.88-2.63],0.1315569487763122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,7798,79,0.90 [0.41-1.98],0.7954139341131636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,9137,86,1.45 [0.72-2.92],0.3015050304953496
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,9173,88,1.40 [0.84-2.34],0.1924136319481358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,7841,81,0.78 [0.42-1.47],0.4462903474201268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,7841,81,0.83 [0.61-1.12],0.2123600982645846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,9245,88,1.22 [0.93-1.60],0.1543221561938363
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,9137,86,1.23 [0.76-2.01],0.4009845140453122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,8011,80,0.90 [0.54-1.50],0.677489707060118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,7841,81,0.93 [0.59-1.48],0.7729219416974239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,8046,81,1.05 [0.68-1.63],0.8147934145912874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,8023,82,0.95 [0.61-1.50],0.833361745140189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,9008,86,1.05 [0.63-1.73],0.8614556779613054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,7841,81,0.79 [0.44-1.43],0.4406689099972721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,8035,82,0.74 [0.32-1.70],0.4756115541882434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,8972,86,1.02 [0.73-1.43],0.9174349711320016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,7921,80,1.18 [0.97-1.42],0.0945545233218478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,9151,89,1.02 [0.63-1.64],0.9433250193246832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,9151,89,1.15 [0.74-1.80],0.5355854743023981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,9252,88,1.08 [0.77-1.50],0.6566473210253027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,8023,82,1.14 [0.66-1.98],0.6360780636970066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,9282,86,1.29 [0.71-2.32],0.4048020163419262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,8972,86,0.86 [0.58-1.27],0.4482545139763672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,9149,88,1.23 [0.64-2.37],0.542088751557104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,9008,86,1.28 [0.86-1.90],0.2187620276219181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,8023,82,1.26 [0.84-1.87],0.2656465857354006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LXN,Latexin,9072,87,0.98 [0.73-1.31],0.8857895224308687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,9156,87,0.98 [0.59-1.62],0.936675642396442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,9151,89,0.90 [0.55-1.46],0.6571523673888564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,9078,85,1.02 [0.52-1.98],0.9596232710592588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,9110,87,1.00 [0.58-1.74],0.9889716875465012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,8972,86,1.11 [0.81-1.53],0.512770157995158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,9137,86,0.99 [0.79-1.25],0.959938324715635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,8948,82,0.92 [0.66-1.30],0.6493815309139042
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,9130,89,0.90 [0.51-1.58],0.7120886686956817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,8972,86,0.96 [0.64-1.43],0.8241273066045638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,7783,80,0.86 [0.67-1.09],0.2031400816921632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,7841,81,1.00 [0.82-1.23],0.9748109410818304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,8065,80,2.05 [0.71-5.94],0.1845395423375115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,7775,79,1.19 [0.67-2.14],0.5544524122603129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,7902,78,0.97 [0.71-1.32],0.8380189305669417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,7871,79,0.49 [0.23-1.04],0.0650623647960774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,9072,87,1.28 [0.94-1.75],0.1136702082891858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,8972,86,1.44 [1.00-2.08],0.0498665315180295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,7841,81,0.97 [0.62-1.52],0.891272235907229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,7921,80,1.04 [0.80-1.34],0.7867059758497698
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,8972,86,0.78 [0.51-1.18],0.2391663864544502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,8046,81,1.29 [0.71-2.32],0.403939151234829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,8023,82,1.19 [0.81-1.75],0.3718883977690388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",7871,79,0.75 [0.31-1.80],0.5178504525995135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,8046,81,1.16 [0.81-1.67],0.4183936937232264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",7775,79,0.76 [0.49-1.19],0.2269013669629873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,9220,88,0.96 [0.82-1.13],0.6429475723285176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,9214,89,1.33 [0.67-2.63],0.4180875548340674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,7802,75,0.90 [0.65-1.25],0.5279798520209691
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,7783,80,0.83 [0.41-1.65],0.5889175436528664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,7802,75,1.10 [0.82-1.46],0.537562688414853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,8042,80,0.87 [0.53-1.43],0.5906722400150375
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,8011,80,0.91 [0.65-1.29],0.6073446596531508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,9151,89,0.93 [0.77-1.12],0.4285645065600694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,8972,86,0.99 [0.81-1.20],0.904493770600697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,9091,87,0.95 [0.80-1.12],0.5374243906072732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,7775,79,0.82 [0.48-1.40],0.4642302719984817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,9151,89,1.07 [0.69-1.66],0.7714477261760306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,7921,80,0.96 [0.71-1.30],0.8079790324691847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,7775,79,0.94 [0.79-1.11],0.4735461316330175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,8948,82,0.88 [0.62-1.24],0.4535606816014289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,9173,88,1.24 [0.60-2.53],0.5599442970420188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",7888,78,0.88 [0.68-1.14],0.3386773041915928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,9091,87,1.58 [0.69-3.62],0.2778830139193584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,9190,88,2.03 [1.08-3.82],0.0277143477204445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,9096,87,0.80 [0.43-1.47],0.4681434652548708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,8972,86,0.92 [0.74-1.14],0.4539165893837777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAX,Protein max,8948,82,1.10 [0.91-1.32],0.3451545174500969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,9282,86,1.19 [0.82-1.71],0.357164001698617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,7947,76,0.89 [0.72-1.09],0.2466874688631187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,9224,85,0.81 [0.46-1.44],0.4706035798654421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",8035,82,1.16 [0.73-1.85],0.5263004117841974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,7830,79,1.11 [0.88-1.39],0.3736689617693834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,9124,88,0.89 [0.57-1.40],0.6174839818445108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,8011,80,1.34 [0.66-2.74],0.4213339920367794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,9110,87,0.82 [0.63-1.08],0.1639069905628433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",8005,80,1.06 [0.62-1.80],0.835562267688015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDK,Midkine,9196,89,1.03 [0.72-1.46],0.8837212059343315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,7841,81,1.03 [0.52-2.06],0.9326080114336376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",7871,79,1.01 [0.79-1.28],0.95582389953409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,8972,86,0.97 [0.75-1.25],0.8063592252682231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,7802,75,0.58 [0.31-1.08],0.0849771811327996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,9173,88,1.28 [0.76-2.14],0.3563709155902208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,7802,75,0.81 [0.40-1.67],0.5747112040623639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,9264,86,1.28 [0.48-3.41],0.6266333838520135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,8046,81,1.20 [0.57-2.50],0.6317764556035975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,7902,78,0.40 [0.16-1.02],0.0556108585787152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,8011,80,0.85 [0.62-1.16],0.3064001874033621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,9173,88,1.02 [0.87-1.19],0.8135371788677466
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,9173,88,1.24 [0.61-2.52],0.5607587739715492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,9266,87,1.19 [0.58-2.45],0.63830482489914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,9182,88,0.96 [0.82-1.12],0.5790647973804921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,9196,84,0.61 [0.24-1.57],0.3049726090438333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,8948,82,1.37 [0.75-2.50],0.3107655849687712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",9151,89,0.99 [0.78-1.24],0.898814987335866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,9234,88,1.07 [0.77-1.49],0.6728054068163803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,8996,83,1.15 [0.81-1.63],0.4335437947053584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,7841,81,0.85 [0.58-1.23],0.3834370580806563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,7902,78,1.22 [0.61-2.44],0.568352974440568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,9282,86,1.56 [0.96-2.51],0.0697395050493078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,9182,88,1.12 [0.72-1.75],0.6148501489777318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,9202,88,0.89 [0.72-1.10],0.28061930507218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,9151,89,0.96 [0.82-1.11],0.5537615111220434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,9214,89,1.20 [0.73-1.95],0.476425911257701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,7841,81,0.88 [0.64-1.23],0.4584614469814801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,9151,89,0.96 [0.86-1.08],0.5388285290535754
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,9171,86,0.95 [0.72-1.26],0.7213431931708709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,9008,86,1.01 [0.69-1.48],0.9521999218020478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,8023,82,0.91 [0.74-1.10],0.3199407300356404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,8042,80,0.95 [0.76-1.20],0.692088322426478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,9110,87,0.92 [0.75-1.11],0.3756418393836728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,7830,79,1.05 [0.62-1.78],0.8629765229380536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,7775,79,0.81 [0.56-1.19],0.2844597182015925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,9151,89,1.11 [0.90-1.37],0.3257928549534623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,9137,86,0.97 [0.77-1.23],0.8038171407174961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,8818,82,0.94 [0.76-1.16],0.5721322799608715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,9153,88,1.30 [0.96-1.76],0.0869400644375427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,9174,88,1.46 [1.03-2.05],0.0316619501945736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,8948,82,1.35 [0.75-2.43],0.3192902883595399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,8046,81,0.92 [0.58-1.46],0.719859671117796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,9182,88,1.39 [0.97-1.99],0.0731443341932079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,8981,83,1.08 [0.71-1.63],0.7156470782791651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,9225,88,1.15 [0.89-1.48],0.2828385569303747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,9162,88,1.22 [0.89-1.67],0.2218969348636274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",7802,75,0.88 [0.54-1.42],0.588711326668433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,7841,81,1.10 [0.78-1.54],0.5937990536541442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,7921,80,0.91 [0.54-1.52],0.7142135968344645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,9156,88,0.96 [0.79-1.16],0.6757924641128847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,7902,78,0.82 [0.58-1.16],0.2724074048196944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,9252,88,0.99 [0.56-1.75],0.9721373935021194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,8042,80,1.38 [0.72-2.63],0.3368201332638082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,7921,80,0.96 [0.57-1.62],0.885901160792043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,7775,79,1.09 [0.63-1.89],0.7514037942401864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,7775,79,0.96 [0.71-1.28],0.7671515664598056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,8996,83,0.93 [0.71-1.21],0.5689104634280525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,9137,86,0.97 [0.77-1.22],0.7843430929462278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,9202,88,0.90 [0.70-1.14],0.3717569683529378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,9182,88,0.78 [0.52-1.18],0.2453471064668531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,8002,82,0.78 [0.47-1.29],0.329560958824674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,8052,80,1.22 [0.59-2.50],0.5930591929421619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,7841,81,0.94 [0.69-1.28],0.6851916981579591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",7802,75,1.30 [0.77-2.17],0.3247729396082898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",8035,82,1.34 [0.90-1.99],0.1440304588466874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",8948,82,1.17 [0.58-2.33],0.6594325883377552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",7761,79,0.69 [0.29-1.66],0.4104634726768149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",8035,82,1.33 [1.07-1.66],0.0103125017183258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",7830,79,0.90 [0.40-2.04],0.8061486450311917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,9119,85,1.15 [0.83-1.60],0.3952208510668883
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,7841,81,0.81 [0.45-1.46],0.4754946338517245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,9134,84,0.89 [0.68-1.16],0.398719171337326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,9245,88,1.16 [0.75-1.78],0.4993079547607491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,9214,89,0.97 [0.75-1.25],0.8000521711302482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,7917,77,0.89 [0.67-1.18],0.4124811455885472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,8996,83,1.27 [0.86-1.86],0.2311569230891516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,7830,79,1.06 [0.83-1.34],0.6544381868085185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",8042,80,1.35 [0.64-2.86],0.4291129840771847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,7921,80,0.97 [0.79-1.18],0.7396308512514902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",8011,80,0.94 [0.73-1.20],0.6249198393862435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,8996,83,1.06 [0.60-1.87],0.8427053977078889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,7802,75,0.89 [0.61-1.30],0.5591560536875042
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,8011,80,0.91 [0.75-1.11],0.3556761833935551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,8023,82,0.94 [0.75-1.17],0.5847213116778801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,7921,80,1.12 [0.77-1.63],0.5644717824740975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,8948,82,1.19 [0.80-1.77],0.3816781191349867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,9137,86,1.12 [1.00-1.25],0.0442303785568355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,8062,80,1.07 [0.85-1.34],0.5650655268428996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,7775,79,0.93 [0.55-1.57],0.7796109590995556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,9008,86,1.08 [0.84-1.37],0.559146383032971
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,7902,78,0.41 [0.21-0.83],0.012745660372575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",8046,81,1.07 [0.78-1.47],0.6659309841211403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",7871,79,0.96 [0.73-1.26],0.7735596541016716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,8035,82,0.97 [0.70-1.33],0.835119987295843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,8046,81,0.98 [0.79-1.22],0.8631982380979024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,7802,75,1.24 [0.82-1.87],0.3148481457263355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,7775,79,0.95 [0.57-1.57],0.8266437263235706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,8062,80,0.93 [0.77-1.13],0.4787805635185094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",7802,75,1.54 [1.09-2.16],0.0130563048152262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,7871,79,1.11 [0.81-1.51],0.5222859840289105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,7871,79,1.16 [0.80-1.67],0.4347416044523593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,7841,81,1.03 [0.82-1.30],0.8145822791834036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",7841,81,0.60 [0.31-1.15],0.1205369702593806
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,8035,82,0.69 [0.35-1.34],0.2704149165724157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,9008,86,0.88 [0.65-1.19],0.3971170224320605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,9182,88,0.81 [0.53-1.22],0.3105425751578862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,7783,80,0.98 [0.63-1.53],0.938683913527788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,7802,75,0.99 [0.60-1.63],0.9542585819809792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,7902,78,1.01 [0.80-1.30],0.9060207904967306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,9208,88,1.15 [0.81-1.63],0.4479779318946685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,8972,86,1.00 [0.69-1.45],0.996500959360342
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,7802,75,1.03 [0.67-1.60],0.8801542956883912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,7841,81,0.99 [0.82-1.19],0.9207936953789552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,9067,87,0.87 [0.62-1.22],0.4084092907579509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,8023,82,0.82 [0.54-1.24],0.3388995798562267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,9173,88,1.13 [0.83-1.55],0.4273493266382583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,7811,79,0.80 [0.51-1.28],0.3565364170452024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,7858,79,0.85 [0.57-1.28],0.4419384704137599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,7902,78,0.55 [0.21-1.45],0.225082888073355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,8972,86,1.13 [0.82-1.55],0.4548937058493857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,7997,80,0.81 [0.48-1.35],0.4137981955962947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,8042,80,1.27 [0.72-2.25],0.403594925139554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",8035,82,0.85 [0.55-1.33],0.4800571425413086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,9214,89,1.84 [0.93-3.63],0.0775991862229487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,9008,86,1.20 [0.89-1.61],0.2319382620257246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,9224,85,1.02 [0.51-2.04],0.9503259596406473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,9182,88,0.55 [0.27-1.13],0.1039570399284656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,9245,88,0.87 [0.53-1.44],0.5894969163680602
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,9139,89,0.84 [0.66-1.07],0.1534707490532761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,9220,88,0.97 [0.81-1.16],0.723632099364421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,9008,86,0.85 [0.54-1.33],0.4832452920595419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,9138,89,1.25 [0.75-2.09],0.3826073650168996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,8011,80,0.85 [0.44-1.64],0.6246064232268576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,9252,88,1.51 [0.78-2.95],0.2241067189121137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,8948,82,0.92 [0.67-1.26],0.6019657555521636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,8023,82,0.88 [0.60-1.28],0.4956281771935361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,7819,79,0.52 [0.27-0.99],0.0470937793812133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,8011,80,0.94 [0.74-1.21],0.6480665085291761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",8972,86,1.06 [0.84-1.35],0.6152182841175943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,7802,75,1.34 [0.84-2.12],0.2166669639341796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,7802,75,1.14 [0.84-1.55],0.3840908909290584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,7830,79,1.03 [0.53-2.02],0.9258130297845256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,9157,88,1.35 [0.72-2.53],0.3507779148038943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,9214,89,2.06 [1.31-3.22],0.0016102298533773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,7830,79,0.96 [0.62-1.49],0.8474077478413472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,7830,79,1.67 [1.05-2.66],0.0316950789123457
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,8913,82,1.08 [0.67-1.72],0.7559286608725143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,7921,80,1.04 [0.80-1.36],0.7509009211282941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,9214,89,1.33 [0.87-2.05],0.1928195372001405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,9220,88,0.57 [0.29-1.13],0.1074935692971866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,8023,82,0.92 [0.75-1.14],0.4528044512956763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,8035,82,1.03 [0.39-2.72],0.9590131681789624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,8052,80,0.90 [0.66-1.24],0.5312663056401739
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,9266,87,1.16 [0.58-2.31],0.670862796530715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,7830,79,0.84 [0.64-1.10],0.2084391633930606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",9151,89,0.92 [0.75-1.12],0.3942469977885635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",9008,86,1.10 [0.80-1.52],0.5554076884629784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,7871,79,0.80 [0.59-1.08],0.1370253826866972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,8035,82,1.03 [0.64-1.65],0.9011498081624172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,7802,75,0.91 [0.66-1.24],0.5413985754506765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,7921,80,0.65 [0.36-1.15],0.1388957033993018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,8972,86,0.92 [0.62-1.37],0.6820677357369609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",8011,80,0.98 [0.79-1.21],0.8527473054053198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,7802,75,0.95 [0.67-1.33],0.7610491021685336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,7802,75,0.86 [0.46-1.60],0.6396466368168214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,9110,87,3.34 [0.65-17.26],0.150641783243156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,8046,81,1.06 [0.52-2.16],0.8833267027558477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,8042,80,1.42 [0.61-3.34],0.4151615324411863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,7712,77,0.88 [0.43-1.78],0.7186805394369177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,9186,85,1.00 [0.62-1.61],0.9872297080950536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,9182,88,0.93 [0.73-1.19],0.5681732372736005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,8972,86,0.93 [0.64-1.36],0.7184476658153305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,7871,79,0.88 [0.57-1.36],0.5578913103731784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,8012,81,0.96 [0.71-1.28],0.7661950162098741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,7841,81,0.86 [0.60-1.24],0.416396516836074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,7783,80,1.02 [0.67-1.56],0.9212801887124586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,7830,79,1.91 [0.79-4.62],0.1492668993399385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,9190,88,0.34 [0.18-0.65],0.0009017830807758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,7994,82,0.90 [0.66-1.23],0.5028792502609291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,9110,87,0.96 [0.73-1.25],0.7460873386150911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,7775,79,0.40 [0.19-0.87],0.0202274889657848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,8035,82,0.92 [0.66-1.29],0.6308853804533516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,9182,88,2.26 [1.03-4.96],0.0413301033483702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,7802,75,1.07 [0.89-1.29],0.4831779879905582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",8948,82,0.79 [0.52-1.19],0.2631320022649696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",7802,75,0.99 [0.56-1.77],0.9793338692630936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",8948,82,0.78 [0.52-1.17],0.2330445376573663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,9282,86,1.03 [0.30-3.59],0.960008208549797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,8062,80,1.11 [0.39-3.14],0.8427102140190996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,9282,86,0.70 [0.40-1.23],0.2181942471485152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,7914,79,0.94 [0.47-1.86],0.8608354466927433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,9173,88,1.19 [0.67-2.14],0.5501795145306378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,7830,79,1.02 [0.53-1.99],0.9450919222637868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,7830,79,0.92 [0.73-1.15],0.4629349321386291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,8046,81,1.26 [0.80-2.00],0.3188239167256096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,8996,83,0.95 [0.83-1.10],0.5066997539927096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,9151,89,1.51 [1.02-2.23],0.0380461904043388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,7802,75,1.44 [0.91-2.26],0.1184788211433777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,8972,86,0.92 [0.71-1.19],0.5228960268046705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,9182,88,1.09 [0.67-1.79],0.7203734709787277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,8062,80,0.54 [0.27-1.05],0.0699787265165269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,9173,88,0.51 [0.28-0.94],0.0321510639307513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,9252,88,1.06 [0.79-1.42],0.6935489011812132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,9173,88,0.94 [0.48-1.83],0.8469270076829167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,8052,80,0.95 [0.75-1.20],0.6633937934422212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,8035,82,1.18 [0.71-1.98],0.5242040302721405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,9238,85,1.11 [0.56-2.19],0.7726703691845166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,9182,88,1.12 [0.59-2.14],0.7314324909990955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,9008,86,0.98 [0.67-1.43],0.9274380853254676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,7841,81,0.88 [0.47-1.64],0.6890273731081591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,9245,88,0.94 [0.71-1.25],0.663144421673348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",8046,81,1.00 [0.75-1.34],0.998488309308646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,8042,80,1.03 [0.52-2.01],0.939927161949681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,9140,89,0.93 [0.75-1.16],0.5313413198054446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,9214,89,1.07 [0.78-1.46],0.687964615025791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,9151,89,1.40 [0.87-2.24],0.1616682725074579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,8972,86,1.01 [0.62-1.63],0.9786195326227968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,9173,88,0.91 [0.43-1.93],0.8136755841377334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,9245,88,0.71 [0.30-1.67],0.4320577411318997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,9173,88,0.90 [0.74-1.08],0.2469738106582308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,9151,89,0.95 [0.76-1.20],0.6726329744581827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,8023,82,0.86 [0.67-1.10],0.2267808681429974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,9235,87,1.04 [0.62-1.74],0.8956572990045133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,9266,87,1.00 [0.73-1.36],0.9910963729368332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,7871,79,1.01 [0.43-2.36],0.9876058255919428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,7802,75,0.81 [0.49-1.34],0.4147795596389336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,7993,79,0.95 [0.73-1.22],0.6612340067413911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],9137,86,0.92 [0.65-1.30],0.6260391176242914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,9182,88,1.03 [0.71-1.50],0.8709170221636714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,7830,79,0.99 [0.76-1.30],0.9560644091818512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,7802,75,0.61 [0.26-1.41],0.2465640344785021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,7802,75,1.19 [0.69-2.07],0.5253818649668291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,8948,82,0.65 [0.38-1.12],0.1239245209141763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,7830,79,0.77 [0.38-1.55],0.4655344189773238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,9082,86,1.03 [0.76-1.41],0.8348653414361151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,8035,82,0.92 [0.56-1.51],0.7494493668624713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,8937,82,1.08 [0.78-1.49],0.6594001964074034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,7921,80,0.77 [0.51-1.15],0.2049974499222629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,8011,80,0.93 [0.68-1.28],0.6721238319874197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,9137,86,0.88 [0.49-1.59],0.6805062156575223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,9182,88,1.19 [0.75-1.87],0.4581458401474028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,7921,80,0.85 [0.58-1.25],0.4182920249231669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,7599,74,0.88 [0.74-1.06],0.1862906636637795
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,9099,88,1.01 [0.73-1.39],0.9574059755345148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,9220,88,1.02 [0.66-1.57],0.9331503065428044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,9137,86,0.78 [0.58-1.05],0.1069595331533396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,7783,80,0.71 [0.43-1.19],0.1934259160692091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,8042,80,0.90 [0.73-1.10],0.292261158798648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,7871,79,0.85 [0.61-1.19],0.3521440148697281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,9137,86,1.35 [0.97-1.87],0.0706343968034242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,8037,80,0.60 [0.20-1.81],0.3627881604663771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,8042,80,1.00 [0.59-1.69],0.9873088481418332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,9190,88,1.18 [0.68-2.08],0.5535163761507728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,9121,89,1.09 [0.84-1.42],0.5195786839831202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,9238,85,1.24 [0.49-3.18],0.6483963241218551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,7841,81,0.60 [0.31-1.16],0.1294747878977481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,7783,80,1.02 [0.68-1.51],0.9409107128808318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,8011,80,0.86 [0.60-1.25],0.4370127792733671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,8035,82,1.00 [0.70-1.41],0.9784754496391244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",7871,79,0.93 [0.67-1.29],0.6675476104562061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,9245,88,1.04 [0.90-1.20],0.6040280444342772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,9137,89,1.01 [0.62-1.66],0.9647289405940472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,7802,75,0.98 [0.68-1.42],0.9248603775025396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,9008,86,1.02 [0.73-1.43],0.8934275795913692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,8937,82,1.01 [0.78-1.31],0.9405296338639556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,9110,87,1.57 [1.31-1.88],7.865402410786207e-07
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,8035,82,1.04 [0.87-1.23],0.6941684207882215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",7921,80,0.75 [0.47-1.20],0.2287695688217564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,8996,83,1.05 [0.74-1.48],0.800261604568641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,7871,79,0.75 [0.44-1.29],0.2984409622031228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,7760,79,0.71 [0.45-1.13],0.1472578076867974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,8948,82,0.93 [0.67-1.29],0.6629976265763056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,7830,79,1.05 [0.63-1.76],0.8400464703863567
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,7965,80,1.01 [0.49-2.08],0.9824543832711566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,8042,80,1.50 [0.85-2.63],0.1613977258732555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,7802,75,1.01 [0.75-1.38],0.9272775594420192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,9230,86,0.93 [0.48-1.83],0.841621324644211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,9182,88,0.96 [0.47-1.95],0.9068101178367022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,9008,86,0.72 [0.48-1.10],0.1260056524633041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,7921,80,0.85 [0.61-1.18],0.3303215370765787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,9182,88,0.89 [0.62-1.27],0.5160388929708501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,9151,89,1.20 [0.93-1.54],0.165535653186419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,7902,78,0.99 [0.61-1.60],0.9635724769129628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,7775,79,1.49 [0.74-3.02],0.2673391612979862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,8948,82,0.76 [0.50-1.14],0.177064849757881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,8011,80,1.14 [0.56-2.34],0.7125455797997484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,7783,80,0.89 [0.66-1.18],0.4117986118317194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,7892,78,1.02 [0.64-1.65],0.9238427015812424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,8035,82,0.95 [0.70-1.28],0.7310111136599964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,9237,86,1.33 [0.59-3.01],0.4984206637755806
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,8035,82,1.96 [0.89-4.30],0.0938361048189038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,9173,88,1.20 [0.70-2.04],0.5083590721347091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,8011,80,0.71 [0.35-1.45],0.3424301188661848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,8011,80,1.47 [0.78-2.77],0.238759661185276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,8023,82,1.38 [0.83-2.30],0.2172543312330436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,7775,79,0.82 [0.54-1.26],0.3692301122358388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,8023,82,0.88 [0.54-1.44],0.6133022514105748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,9282,86,1.15 [0.71-1.86],0.575712441230609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,8011,80,1.04 [0.78-1.39],0.7774969691047446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,8046,81,1.00 [0.80-1.25],0.9881104980809714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,9237,88,1.31 [0.88-1.93],0.1789573661010209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,9137,86,0.71 [0.38-1.32],0.274872817185175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,9245,88,0.97 [0.70-1.34],0.8605562424611787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,9173,88,1.16 [0.84-1.59],0.3686468465874791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,7775,79,1.17 [0.84-1.64],0.3474769963992267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",7775,79,0.91 [0.60-1.40],0.6770318516511101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",7802,75,1.07 [0.77-1.51],0.6757984435468312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",7902,78,0.92 [0.75-1.14],0.4558244146671302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,9282,86,0.91 [0.70-1.19],0.4960815764135433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,9220,88,0.90 [0.73-1.12],0.3521993127953315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,8972,86,1.16 [0.63-2.15],0.6380161036486256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,9173,88,1.63 [0.86-3.09],0.1308497319370295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,9282,86,0.64 [0.38-1.08],0.0971239463849276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,7775,79,0.99 [0.59-1.67],0.9737641770105704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,7902,78,1.00 [0.41-2.45],0.993463997476635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,8062,80,0.90 [0.62-1.30],0.5727437132558588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,7775,79,0.93 [0.63-1.36],0.69998138093876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,8035,82,0.95 [0.79-1.14],0.5880778269774904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,9220,88,0.94 [0.80-1.09],0.3950757581471695
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",8972,86,0.89 [0.59-1.35],0.5874436443347683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,7841,81,0.68 [0.41-1.12],0.1309415230525744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,7775,79,0.93 [0.61-1.40],0.7122707505448276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,7802,75,1.01 [0.70-1.46],0.9483354202651212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,7830,79,1.00 [0.59-1.67],0.989756869197264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,9282,86,0.59 [0.26-1.35],0.2129115615691311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,9182,88,0.93 [0.67-1.29],0.6581006282142949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,9182,88,0.67 [0.35-1.26],0.214725196586154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,7871,79,0.54 [0.23-1.27],0.1552046676038796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,7902,78,0.60 [0.29-1.23],0.1606976685430908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,8052,80,1.32 [0.59-2.96],0.5053728922823597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,7830,79,1.05 [0.88-1.25],0.5732158130452092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,8011,79,0.87 [0.70-1.09],0.2238541756589271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,8948,82,0.96 [0.68-1.37],0.8415731494983002
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,7775,79,0.68 [0.42-1.10],0.1147518966640502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,7841,81,0.87 [0.60-1.26],0.4620005827858298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",9116,86,0.88 [0.69-1.13],0.3316730236799936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,8052,80,1.09 [0.83-1.44],0.538118736196108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",8046,81,1.25 [0.85-1.84],0.2490456310565156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,9266,87,1.21 [0.56-2.63],0.6238821103365082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,9253,86,0.88 [0.56-1.40],0.5915765233433136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,7962,77,0.95 [0.46-1.93],0.877533244382304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,7802,75,1.02 [0.71-1.46],0.9075462160829648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,7841,81,1.07 [0.75-1.52],0.7108088498867389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,7830,79,0.78 [0.56-1.07],0.1246742569074287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,8035,82,0.99 [0.82-1.20],0.942186311205348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,8011,80,0.90 [0.60-1.37],0.6360349609525016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,7775,79,0.93 [0.73-1.19],0.5858827594651059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,9110,87,1.67 [0.87-3.20],0.1200962918900835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,7902,78,0.71 [0.42-1.20],0.2046536126776793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,8052,80,1.97 [0.84-4.62],0.1194045938051854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI3,Elafin,9061,83,1.03 [0.72-1.46],0.882025356019243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",8035,82,1.04 [0.79-1.37],0.7695751312242092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,9060,85,1.30 [0.74-2.25],0.3596102254278236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,9151,89,0.84 [0.61-1.16],0.2876392639171233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,9182,88,1.24 [0.62-2.47],0.5402567919587304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,7830,79,0.96 [0.64-1.44],0.843462339910785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,9182,88,1.11 [0.70-1.74],0.6622850715743873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,9173,88,1.07 [0.76-1.49],0.7002338600733542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,7902,78,0.98 [0.72-1.35],0.907666755249052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,7760,79,1.09 [0.86-1.39],0.4631472388981359
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,8046,81,1.29 [0.56-2.94],0.5513394063062845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,7802,75,0.96 [0.65-1.43],0.8503797112974221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,9196,88,0.92 [0.69-1.22],0.5589759380244442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,7921,80,0.82 [0.61-1.11],0.1955700163903167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,9110,87,0.86 [0.63-1.17],0.3472341798561503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,9214,89,0.99 [0.48-2.05],0.9739622209766372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,9270,86,0.98 [0.63-1.51],0.916392037775166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",9137,83,1.24 [0.94-1.65],0.1313629047666686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,9220,88,0.92 [0.74-1.14],0.4365121234456482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,9182,88,0.99 [0.56-1.77],0.9841777707577956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,9264,86,1.19 [0.81-1.75],0.3826846325759097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,9182,88,0.89 [0.46-1.72],0.7320451223497908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,9121,88,1.35 [0.68-2.71],0.3933299138200272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",8042,80,1.01 [0.71-1.45],0.9487508302563354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",7830,79,1.05 [0.65-1.71],0.8400258704534502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",8042,80,0.97 [0.77-1.21],0.7880060171358867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,8042,80,0.93 [0.68-1.27],0.6427289072906297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,7863,74,1.17 [0.41-3.33],0.7676360004064307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,8948,82,0.86 [0.47-1.56],0.6126946110592707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,9173,88,0.88 [0.56-1.39],0.594973702545635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,9173,88,0.92 [0.70-1.22],0.5779456412930997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,8025,80,0.78 [0.54-1.13],0.1952903728923299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,9252,86,0.58 [0.34-0.98],0.0423250983620745
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,8972,86,1.04 [0.58-1.86],0.9039147193079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,8042,80,0.95 [0.43-2.09],0.8990373778343473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,9151,89,0.98 [0.78-1.23],0.8585475122703381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,9245,86,0.72 [0.31-1.66],0.4410028324436591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,9149,88,0.74 [0.49-1.13],0.1668271758101757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,9125,88,0.99 [0.89-1.10],0.868017962655453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,7802,75,1.19 [1.00-1.42],0.055207528547074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,7802,75,0.77 [0.52-1.14],0.190016413694477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,7841,81,0.96 [0.62-1.47],0.8407157729153607
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,8930,82,0.97 [0.81-1.16],0.7493335285265628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,8052,80,1.01 [0.71-1.42],0.9734108463009882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,8042,80,0.98 [0.74-1.30],0.908394502354484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,9173,88,0.97 [0.91-1.03],0.2595933792504703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,7871,79,1.27 [0.88-1.84],0.2035267352207904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,7783,80,1.21 [0.77-1.90],0.4131283153065848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",9008,86,0.98 [0.82-1.17],0.8232316613359786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,9137,86,1.21 [0.35-4.24],0.7643186553720479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,9214,89,1.73 [0.91-3.30],0.0928294321728423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,7830,79,0.80 [0.48-1.33],0.3905204146728455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,7830,79,0.66 [0.29-1.47],0.304394350754488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",9137,86,1.05 [0.60-1.82],0.868084435742871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,7871,79,0.92 [0.67-1.28],0.6311829552879491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,8052,80,0.95 [0.43-2.12],0.9094453162501576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,8996,83,1.37 [0.78-2.40],0.2671512361599873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,9220,88,0.71 [0.41-1.23],0.21883929738143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,8062,80,1.02 [0.57-1.83],0.9403521040046672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,8012,78,0.87 [0.67-1.12],0.2670504482847092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,9245,88,0.87 [0.58-1.31],0.5054971122737435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,9193,85,1.01 [0.82-1.24],0.9074545646093362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,7921,80,0.96 [0.68-1.35],0.8106845077206692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",8062,80,0.92 [0.64-1.31],0.6358045423188565
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,7830,79,1.00 [0.53-1.92],0.9901705683872772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,8972,86,1.48 [0.94-2.33],0.0927881338151214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,7830,79,0.74 [0.47-1.18],0.2122186401332788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,8046,81,0.91 [0.60-1.38],0.6620036650729073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,9137,86,0.92 [0.67-1.25],0.584879329931864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,8023,82,0.91 [0.70-1.19],0.4951246880647136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,9214,89,0.99 [0.82-1.20],0.9235269852061784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,7921,80,0.91 [0.66-1.26],0.5848973584175166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,8035,82,0.97 [0.74-1.28],0.8466078042588787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,8035,82,0.89 [0.50-1.59],0.7013077556998308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,9173,88,0.94 [0.74-1.20],0.6094170669453312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,9266,87,1.04 [0.85-1.27],0.714840135058692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,8011,80,0.96 [0.80-1.16],0.6634153561480389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,9110,87,0.92 [0.57-1.47],0.7257112985719121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,7841,81,0.96 [0.71-1.29],0.7837152433932025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,9187,89,1.13 [0.95-1.35],0.1743255065388821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,8972,86,1.12 [0.83-1.53],0.4484384869421153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,7775,79,1.69 [0.82-3.46],0.1536781569949394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,8062,80,0.84 [0.51-1.39],0.4964828048744696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,8023,82,0.94 [0.57-1.56],0.8059803824880674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,9240,86,0.79 [0.42-1.50],0.4701831150653265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,8927,87,0.90 [0.72-1.13],0.3779240194614888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,7908,76,0.99 [0.70-1.39],0.9555561829434172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",9008,86,1.02 [0.78-1.34],0.8587548490404908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",9266,87,0.95 [0.72-1.26],0.744789449262706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,9252,88,0.96 [0.70-1.32],0.8226942132955731
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,9008,86,1.22 [0.67-2.21],0.5125211125460821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,9173,88,0.75 [0.34-1.63],0.4658410589634065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,8062,80,0.81 [0.54-1.23],0.3250260398316173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,8062,80,0.83 [0.54-1.27],0.387457387960755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,9008,86,1.00 [0.70-1.43],0.9978662451720044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,7841,81,0.82 [0.40-1.69],0.5937996551901474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,9173,88,0.97 [0.77-1.21],0.7830056729409017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,8026,80,0.86 [0.67-1.12],0.2762185278322065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,9008,86,0.97 [0.62-1.51],0.8852008301912038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,7802,75,1.26 [0.88-1.80],0.215966065499471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,7902,78,0.98 [0.82-1.17],0.8153886535831742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,8972,86,0.98 [0.74-1.31],0.9067354643766892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,9245,88,1.05 [0.81-1.36],0.6936112469444828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,8042,80,1.12 [0.76-1.66],0.5568171210958428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,9205,85,1.02 [0.46-2.27],0.9565939640501436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,7802,75,0.68 [0.32-1.43],0.3060689452008212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,9151,89,0.82 [0.59-1.15],0.250541028017018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,8065,80,0.79 [0.33-1.89],0.5904278566847505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,7832,76,1.02 [0.74-1.40],0.8975018188732267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,7830,79,0.85 [0.51-1.43],0.5478962421383082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,7871,79,1.27 [0.74-2.19],0.3863259979907253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,9224,85,1.06 [0.73-1.54],0.7660084010640331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,7830,79,0.81 [0.41-1.58],0.5300286864699235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,9156,88,1.29 [0.81-2.04],0.2798077186047742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,8042,80,1.60 [0.91-2.79],0.1007768115271923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,9156,88,1.55 [1.00-2.40],0.052218858245016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,8948,82,0.99 [0.83-1.18],0.8750782215721247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,9252,88,1.80 [0.85-3.81],0.1226747719402062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,8941,83,0.87 [0.57-1.33],0.5199011467579667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,7921,80,0.89 [0.42-1.90],0.7605227095774892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,7978,79,0.83 [0.38-1.81],0.6304879953369458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,8011,80,0.79 [0.51-1.21],0.2763633002829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,8011,80,1.10 [1.01-1.21],0.0308434452771389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,9110,87,1.07 [0.90-1.26],0.4450346607816776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,9151,89,1.09 [0.83-1.44],0.5281994201567579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,8972,86,1.02 [0.66-1.55],0.9442348526726732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,7775,79,1.08 [0.54-2.16],0.8194248958577925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,8035,82,1.30 [0.87-1.94],0.2033513631597006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,7841,81,0.95 [0.64-1.41],0.8001791531742748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,9137,86,0.99 [0.71-1.40],0.9743622671390382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,9098,87,1.00 [0.61-1.66],0.9902989256199428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,9063,87,0.88 [0.52-1.48],0.6309975533105641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,9151,89,0.84 [0.58-1.21],0.3424307784373256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,7830,79,1.05 [0.72-1.51],0.8044326327401644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,9151,89,1.04 [0.86-1.26],0.685215730791916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,8972,86,1.08 [0.78-1.49],0.6588302364507299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,7647,76,0.99 [0.80-1.22],0.8925598661311612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",8948,82,0.71 [0.37-1.37],0.3036546699218482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,9114,85,1.16 [0.62-2.20],0.6409139723628827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,7766,78,1.06 [0.70-1.59],0.7911303484245592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,8046,81,1.06 [0.82-1.37],0.6780209230540629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,7841,81,1.25 [0.97-1.61],0.0804490964340351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,9151,89,1.15 [0.76-1.72],0.5095628174594298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,8948,82,1.42 [0.85-2.36],0.1825925607622752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,8996,83,0.89 [0.60-1.33],0.5722484477270974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,7830,79,1.08 [0.74-1.58],0.6997017415310223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,9110,87,0.96 [0.75-1.23],0.7508898172445189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,9202,88,0.95 [0.77-1.18],0.6635187160463836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,7818,79,0.91 [0.48-1.73],0.7826722947219893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,8046,81,0.91 [0.42-1.95],0.806843929356907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,8062,80,0.78 [0.29-2.10],0.6266750865406145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,9282,86,1.48 [0.76-2.89],0.2470802173366164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,8011,80,0.89 [0.57-1.40],0.6246492222561717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,8011,80,0.63 [0.21-1.83],0.3934606957658867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,9140,89,0.39 [0.18-0.85],0.0179386553442259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,9083,87,1.30 [0.73-2.30],0.374655289831715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,8042,80,0.70 [0.38-1.29],0.2507416554630334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,9282,86,1.33 [0.60-2.93],0.4844810674414452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,8046,81,0.76 [0.39-1.47],0.4138315291621328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,7902,78,0.94 [0.65-1.35],0.7451901080557278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,8913,82,1.17 [0.83-1.65],0.3585038684677238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,7921,80,0.76 [0.43-1.33],0.3395490742922541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,9151,89,1.56 [1.01-2.43],0.0456985278127081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,9196,88,0.96 [0.82-1.14],0.6623398123502496
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,9245,88,1.64 [1.02-2.64],0.040136838810354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,8023,82,0.78 [0.48-1.26],0.3111659487319345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,8948,82,1.13 [0.78-1.62],0.5154265345079736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,7871,79,0.57 [0.32-1.04],0.0691725118348272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,7802,75,1.10 [0.88-1.37],0.3923780511553791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,8065,80,1.01 [0.71-1.45],0.9447000011677016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,9131,88,0.85 [0.55-1.32],0.4691568138377262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,9212,86,1.34 [0.66-2.71],0.4152616719901879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,7910,80,1.05 [0.64-1.73],0.8323783142765547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,8046,81,1.05 [0.70-1.56],0.8178782094343633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,8046,81,0.92 [0.76-1.13],0.4421454083887913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,8046,81,0.90 [0.70-1.17],0.4402528730344077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,8023,82,0.76 [0.53-1.09],0.1389288757236478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,7802,75,0.88 [0.62-1.24],0.4658660033698671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,9008,86,0.99 [0.78-1.27],0.9548508541342582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,7802,75,1.06 [0.84-1.34],0.6205048753306136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,7783,80,0.96 [0.64-1.44],0.8444418369792124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,8023,82,1.04 [0.64-1.67],0.8870826741807861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,9151,89,1.08 [0.73-1.58],0.7100182558617869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,8948,82,1.03 [0.70-1.53],0.871340292490127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,7902,78,0.90 [0.67-1.19],0.4462130005588767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,8972,86,1.10 [0.80-1.52],0.5441091609878801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,9008,86,0.92 [0.67-1.28],0.62285509621269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,7841,81,1.06 [0.81-1.39],0.6685298030341226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,8972,86,1.03 [0.69-1.55],0.8830097981389392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,7921,80,1.00 [0.67-1.48],0.9911418476507792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,7830,79,1.33 [0.67-2.64],0.4147471540040217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,8023,82,1.20 [0.82-1.75],0.3404381566539283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,7871,79,0.88 [0.59-1.33],0.5488546335628839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,7783,80,1.09 [0.57-2.09],0.8009268821502659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,8972,86,0.87 [0.56-1.35],0.5282780538860006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,7830,79,0.87 [0.61-1.26],0.4648502847744287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,7921,80,0.81 [0.52-1.25],0.3301640438409831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,8972,86,0.79 [0.41-1.50],0.4658520448248574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,9238,85,1.14 [0.75-1.72],0.5355915409943646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,8948,82,1.34 [0.80-2.24],0.2626770681728132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,7775,79,0.89 [0.55-1.46],0.6561907379936485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,8972,86,0.85 [0.58-1.24],0.3881223846157037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,8035,82,1.29 [0.77-2.19],0.334372278619081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,8958,86,1.07 [0.74-1.56],0.7130831573732976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,8035,82,1.08 [0.81-1.42],0.6091904728223227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,7802,75,1.30 [0.91-1.86],0.1481977222773109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,7775,79,1.17 [0.76-1.81],0.4764210551104547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,7841,81,0.85 [0.59-1.24],0.4078480417690273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,9137,86,0.88 [0.68-1.14],0.3213281040819302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,9137,86,1.00 [0.71-1.41],0.9928956663521088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,8011,80,1.02 [0.71-1.45],0.9236401764480566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,7830,79,1.03 [0.76-1.40],0.8533416461945998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,7871,79,0.88 [0.71-1.09],0.2459943221932063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,8023,82,1.19 [0.85-1.67],0.3097777240776875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,8996,83,1.00 [0.64-1.56],0.9935614766802474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,7871,79,0.85 [0.28-2.54],0.7659797852257421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,8035,82,0.94 [0.66-1.33],0.7237370051858495
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,9119,85,1.29 [0.92-1.82],0.1437690720156142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,9282,86,1.23 [0.91-1.66],0.1792377252062942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,9282,86,0.94 [0.69-1.27],0.6789793648391942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,8023,82,1.09 [0.65-1.83],0.7384986905097468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,9190,88,0.81 [0.55-1.18],0.2687929878491734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,7830,79,1.26 [0.89-1.78],0.1959075222497358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,9182,88,1.07 [0.54-2.10],0.851683407087548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REN,Renin,9173,88,1.21 [0.96-1.51],0.103588958878218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,7830,79,1.08 [0.63-1.85],0.7869193983003169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,7775,79,1.06 [0.57-1.97],0.8528548884945019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,9137,86,1.02 [0.63-1.64],0.9419721202423562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RETN,Resistin,9163,85,0.92 [0.58-1.45],0.7117972180128505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",7802,75,0.86 [0.52-1.42],0.5640859395951923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,8023,82,0.91 [0.32-2.58],0.8551189744346727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,8035,82,0.92 [0.69-1.22],0.5483269514050884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,7921,80,1.34 [1.06-1.69],0.0143097691801882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,9245,88,2.18 [1.19-4.00],0.0117151428793694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,9245,88,1.75 [0.88-3.49],0.1123013371953575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,8035,82,0.95 [0.66-1.36],0.7780380486839041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,9008,86,1.10 [0.85-1.44],0.4559518788232828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,9051,87,0.98 [0.83-1.16],0.8341253219341149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,7830,79,1.30 [0.94-1.79],0.1164980304627131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,7902,78,1.21 [0.79-1.84],0.3798937791558427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,9217,88,0.99 [0.72-1.35],0.9482496736398262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,8046,81,0.93 [0.75-1.16],0.5080164346098257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,7802,75,0.98 [0.72-1.35],0.9185854406572636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,8035,82,1.02 [0.67-1.56],0.9152238534951944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,7882,78,0.77 [0.47-1.25],0.2876200640086842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,8052,80,1.62 [0.90-2.93],0.1100427461448336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,7871,79,0.93 [0.59-1.46],0.7627301269763533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,9139,88,0.95 [0.80-1.13],0.5697471343060976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,7779,78,1.10 [0.52-2.34],0.8016118805833721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,7989,80,1.29 [0.72-2.28],0.3901631318731674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,8035,82,0.93 [0.59-1.46],0.7551979554700657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,9250,86,1.59 [0.89-2.82],0.1152749663943083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,7871,79,1.51 [0.80-2.84],0.200224016779688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,7830,79,0.78 [0.43-1.42],0.4113440215120084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,7830,79,0.61 [0.29-1.28],0.1926220435231485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,7921,80,1.22 [0.94-1.58],0.1323616677023826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,8972,86,0.96 [0.72-1.29],0.7943725121905161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,7921,80,1.05 [0.73-1.50],0.8117861253446617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,7871,79,0.98 [0.72-1.33],0.9077288973627268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,9190,88,1.22 [0.57-2.64],0.6084608973408769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,9245,88,1.48 [0.67-3.26],0.3320210011512836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,7871,79,0.91 [0.27-3.10],0.8766563943743378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,9173,88,1.52 [0.84-2.73],0.1654329326496593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,9137,86,0.95 [0.60-1.52],0.8298803793161849
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,7830,79,1.12 [0.56-2.22],0.7466332733859793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,7921,80,0.99 [0.73-1.35],0.9618328998067168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,7841,81,0.89 [0.52-1.53],0.6839969963877345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,7871,79,1.09 [0.64-1.88],0.7494544457211241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,7802,75,0.91 [0.52-1.59],0.7390182640561433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,7841,81,0.92 [0.77-1.09],0.3315232846431815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,8972,86,1.19 [0.89-1.58],0.2402381866771863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,8972,86,0.92 [0.69-1.23],0.5799321812284963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,7783,80,0.89 [0.71-1.12],0.3141088533181908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,9110,87,0.77 [0.43-1.39],0.3906689371538412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,9252,88,1.64 [0.85-3.18],0.1402958844449084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,9137,86,0.95 [0.49-1.87],0.8891523586167738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,7802,75,1.11 [0.76-1.63],0.5796774199417931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",8035,82,1.07 [0.85-1.35],0.5722236484124357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,9252,88,1.59 [0.96-2.63],0.0729114223501688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,8972,86,0.94 [0.78-1.13],0.5163834909722214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,9245,88,1.01 [0.75-1.36],0.9509781150075052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,7802,75,1.45 [0.93-2.24],0.1004523459540071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,9105,87,0.89 [0.57-1.37],0.5852513628079496
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,9048,83,0.95 [0.73-1.23],0.6897544464331491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,7830,79,0.67 [0.34-1.28],0.2251670668406238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,8035,82,0.63 [0.41-0.95],0.0274552943544114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,8937,82,0.87 [0.62-1.20],0.3909520183426209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,8023,82,1.12 [0.74-1.68],0.6007430587301048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,9214,89,0.96 [0.69-1.34],0.8308852008812568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,8035,82,0.70 [0.42-1.16],0.1641359544313323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,8996,83,1.15 [0.84-1.59],0.3799644205426259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,8065,80,1.00 [0.48-2.09],0.995157256851228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,8035,82,0.91 [0.42-1.94],0.7995654153237014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,7783,80,1.37 [1.00-1.87],0.0490841144686445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,9151,89,0.84 [0.64-1.10],0.2007641361413136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,7921,80,1.01 [0.76-1.34],0.9424795348938504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,8011,81,0.97 [0.80-1.19],0.7941055530872291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,7802,75,0.82 [0.41-1.66],0.5838808647448899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,7802,75,0.97 [0.62-1.51],0.8855250775766972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,7921,80,0.89 [0.62-1.26],0.4958042831785187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,8035,82,0.88 [0.40-1.91],0.7423711938396347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,8048,80,1.09 [0.58-2.03],0.7849461192968574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,9137,86,1.01 [0.80-1.26],0.9638698830469224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,9245,88,1.49 [0.79-2.81],0.218346773728471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,8948,82,1.11 [0.82-1.51],0.4984595410734446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,8941,87,1.16 [0.64-2.12],0.6287875636716531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,9282,86,1.08 [0.69-1.70],0.7410764131471193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,9245,88,1.34 [0.71-2.53],0.373126172559995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,9200,87,1.01 [0.56-1.82],0.9689971948049516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,9190,88,0.96 [0.55-1.66],0.8751295429037692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,9183,88,0.99 [0.71-1.38],0.9438897459962236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,7802,75,0.99 [0.48-2.04],0.9768044286998976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,7902,78,0.99 [0.43-2.31],0.9875541416406568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,9202,88,0.86 [0.68-1.08],0.1985007003502419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,9008,86,0.68 [0.44-1.06],0.0904910736873004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,7783,80,0.69 [0.49-0.98],0.0380235736237975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,9217,88,1.10 [0.74-1.65],0.6323771972615939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,7783,80,0.82 [0.49-1.37],0.4533385309254878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,7841,81,0.81 [0.38-1.75],0.5972217662970127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,7841,81,0.91 [0.49-1.69],0.7705957953557931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,7783,80,0.78 [0.46-1.31],0.3419088871013043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,7871,79,1.19 [0.72-1.96],0.5048510824547952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,8972,86,1.02 [0.78-1.32],0.910487768365845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,7838,79,0.95 [0.60-1.50],0.8296166455712191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,8046,81,1.22 [0.57-2.63],0.6033565273672736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,7871,79,0.87 [0.67-1.13],0.3062705699061545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,9151,89,0.92 [0.65-1.30],0.6270940300469103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCT,Secretin,7841,81,0.66 [0.42-1.06],0.083835828137949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,9173,88,1.01 [0.62-1.66],0.9568601834379618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,9173,88,0.85 [0.57-1.29],0.4567954812017769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,8023,82,1.01 [0.84-1.23],0.8805763044631598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,8011,80,1.21 [0.91-1.61],0.1916196103172304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,7902,78,0.76 [0.42-1.38],0.3653688460289399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,7871,79,0.92 [0.69-1.22],0.5540336136724441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,7871,79,0.99 [0.51-1.91],0.9709674221223832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,9282,86,0.76 [0.52-1.10],0.1398863135184437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,8065,80,1.21 [0.48-3.01],0.6850676302031227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,8065,80,0.55 [0.22-1.33],0.1821208020208151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,9224,85,1.02 [0.73-1.43],0.8876463582599177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,9151,89,0.68 [0.35-1.30],0.2404956277653131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,9173,88,1.49 [0.73-3.03],0.275235193213462
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,7902,78,1.20 [0.74-1.96],0.4653210058279374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,9137,86,0.52 [0.24-1.16],0.1096713317074588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,9245,88,0.77 [0.41-1.44],0.4115807918603571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,7830,79,0.83 [0.34-2.01],0.6805714058674768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,9264,86,1.38 [0.69-2.75],0.3623833933405221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,8035,82,1.01 [0.75-1.35],0.9451936568056968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,7921,80,0.70 [0.41-1.18],0.1787890159451206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,8029,80,1.04 [0.52-2.07],0.9164981139710788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,9137,86,0.79 [0.39-1.59],0.5017600187252995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,7902,77,1.31 [0.08-20.70],0.8480650017538356
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,9282,86,1.17 [0.73-1.88],0.5189386476755917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,8889,86,1.09 [0.93-1.28],0.2903657870283669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,8025,80,0.54 [0.12-2.35],0.4111602247569327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,7913,77,1.08 [0.43-2.71],0.8659426269887951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,7943,78,1.03 [0.53-2.00],0.9281705294162164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,8065,80,0.52 [0.13-2.01],0.3396375289055086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,8065,80,1.60 [0.52-4.96],0.4148279095291097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,9086,86,1.04 [0.79-1.35],0.7857555810780024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,9151,86,0.94 [0.76-1.17],0.6094656733631125
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,8996,83,0.99 [0.67-1.47],0.9764107429336576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,9216,88,1.00 [0.72-1.38],0.999904610220816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,9266,87,0.95 [0.68-1.33],0.7560850619220105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,9110,87,0.98 [0.55-1.74],0.9386105992993086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,8047,79,0.37 [0.12-1.17],0.0912795527176116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,8047,79,1.62 [0.72-3.64],0.239050263272706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,9282,86,0.87 [0.66-1.15],0.334863996987911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,8046,81,0.80 [0.57-1.13],0.208349671956499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,7933,76,1.29 [0.57-2.93],0.5470979724137199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,7909,77,0.33 [0.07-1.45],0.1419078270159784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,8047,79,0.73 [0.22-2.40],0.6033896415818434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,7921,80,0.94 [0.80-1.11],0.478367921479283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,7888,78,1.07 [0.53-2.14],0.8540166052206588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,8011,80,1.01 [0.69-1.48],0.9662482734492104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,8948,82,0.97 [0.71-1.32],0.8433325387206632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,9084,87,1.41 [0.76-2.59],0.2727153137736065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,7841,81,0.75 [0.37-1.54],0.4338074248006085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,9214,89,0.82 [0.41-1.63],0.5739928827294682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,9137,86,1.07 [0.47-2.45],0.8647923828523196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,9137,86,0.92 [0.71-1.19],0.5137455850360246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,9088,87,1.04 [0.67-1.62],0.8553877881789018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,7902,78,1.28 [0.73-2.24],0.3896666026994397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,8972,86,1.32 [1.05-1.66],0.0158235094023994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,8972,86,1.38 [0.99-1.94],0.057937960236213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,9173,88,1.05 [0.79-1.39],0.7375094324450209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,7886,81,1.02 [0.70-1.49],0.9177377726389884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,8972,86,0.95 [0.78-1.16],0.6402076787726517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,9151,89,0.73 [0.49-1.08],0.1159442841830575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,7783,80,1.20 [0.90-1.60],0.2072655407816412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,8011,80,0.98 [0.62-1.54],0.9295082094066326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,7877,80,0.93 [0.73-1.20],0.5926695573106857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,8042,80,0.92 [0.67-1.27],0.6078180353206704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,8052,80,0.92 [0.62-1.38],0.6845335502012933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,7775,79,1.08 [0.91-1.29],0.3804965254568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,7783,75,0.87 [0.64-1.17],0.3416012632578265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,7830,79,0.96 [0.58-1.58],0.8596850269690595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,8062,80,1.59 [0.83-3.04],0.1611137305435799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",9202,88,0.99 [0.80-1.24],0.9521447009363476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,7921,80,1.03 [0.62-1.72],0.8972191771495729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,9200,88,0.74 [0.49-1.12],0.1575079295747535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,9220,88,1.09 [0.71-1.67],0.6891420736116991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,9151,89,1.47 [0.84-2.57],0.1777207531855734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,8948,82,1.15 [0.93-1.43],0.2039576931885306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,9182,88,1.01 [0.86-1.18],0.9194224309843086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,9252,88,1.11 [0.63-1.96],0.7275053279406165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,9173,88,0.68 [0.34-1.37],0.2836395436329821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,7871,79,0.83 [0.50-1.35],0.4483265840225714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,9235,88,0.77 [0.40-1.45],0.414829029159338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,7871,79,1.47 [0.95-2.27],0.0850211994565429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,9203,85,1.00 [0.71-1.39],0.9887889218334815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,9167,88,1.23 [0.82-1.84],0.3189801303273214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,7830,79,0.88 [0.64-1.21],0.4379935445522311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,9137,86,0.94 [0.76-1.17],0.5897021783671919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",8948,82,0.85 [0.58-1.25],0.4128302187449488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,9008,86,0.85 [0.60-1.20],0.355023843575885
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,9091,87,0.95 [0.73-1.23],0.7007612674762119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,9220,88,0.93 [0.78-1.12],0.4595517022378322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,7802,75,1.07 [0.63-1.83],0.7914835179709361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,8035,82,1.00 [0.81-1.23],0.996742693430619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,9008,86,0.99 [0.72-1.38],0.9673358079327694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,8972,86,1.10 [0.65-1.84],0.7260072287030936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,9151,89,1.10 [0.80-1.53],0.5487195193481633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,8972,86,0.87 [0.61-1.23],0.4258028490199298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,7802,75,1.45 [0.78-2.70],0.2425408177025383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,8023,82,1.08 [0.79-1.47],0.6400829998218645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,8948,82,1.05 [0.76-1.45],0.774704375549091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,7841,81,1.01 [0.67-1.52],0.9618808985709656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,8948,82,0.94 [0.68-1.29],0.6948390743949289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,7775,79,1.00 [0.70-1.44],0.9938116719336144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,7775,79,1.00 [0.65-1.56],0.9845072637278393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,8948,82,0.94 [0.52-1.69],0.8378175026859821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,9151,89,1.09 [0.78-1.53],0.6005337858808318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,7841,81,1.00 [0.74-1.35],0.9876702523725436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,8062,80,1.51 [0.99-2.31],0.0536672660845266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,7802,75,0.63 [0.44-0.88],0.0078076671485644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,7902,78,1.04 [0.80-1.35],0.7767832471525539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,8011,80,0.87 [0.54-1.41],0.5747082350944517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",7775,79,0.94 [0.63-1.41],0.7708593180575746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,8948,82,0.81 [0.54-1.22],0.3140010234057995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,7830,79,0.98 [0.49-1.94],0.9527796110839192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,9252,88,1.27 [0.77-2.07],0.3504934433291893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,8996,83,1.51 [0.89-2.57],0.1264953202513281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,7921,80,0.82 [0.58-1.15],0.2550282115091582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,8011,80,0.93 [0.72-1.22],0.6105880719034139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,7996,80,1.05 [0.62-1.77],0.860299789479909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,8972,86,1.03 [0.81-1.30],0.8116428237908504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,8023,82,0.81 [0.59-1.13],0.2174236437356291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,8023,82,0.78 [0.51-1.20],0.2568775408291271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,9137,86,0.90 [0.34-2.32],0.8199859540808268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,8948,82,1.04 [0.79-1.38],0.7573548723781487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,7775,79,1.09 [0.76-1.56],0.6422092824464658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,8011,80,0.92 [0.63-1.35],0.6722290947060536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,9252,88,1.09 [0.62-1.94],0.7557669398112581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,9220,88,1.15 [0.69-1.90],0.5920744232103625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,9198,88,1.09 [0.73-1.64],0.6784719356170675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,7830,79,0.64 [0.36-1.13],0.1231781648586764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,9214,88,0.77 [0.58-1.02],0.0716445786322147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,8023,82,1.08 [0.85-1.37],0.5416375400110103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,7783,80,0.77 [0.52-1.14],0.189523842551908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,8036,80,0.83 [0.65-1.06],0.1431115867347178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,9173,88,1.00 [0.80-1.24],0.9812106961627128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,7783,80,0.85 [0.53-1.36],0.4903799878933433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,9214,89,0.98 [0.80-1.21],0.8526600862923603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,8035,82,0.98 [0.67-1.42],0.917328107989729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,7902,78,0.93 [0.76-1.13],0.4487291491935753
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,9110,87,1.06 [0.80-1.41],0.6850502209211669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",7871,79,1.37 [0.79-2.36],0.26305052662946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',8042,80,1.12 [0.73-1.73],0.603660427779884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,7802,75,0.94 [0.64-1.38],0.7548666802939532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,7902,78,0.96 [0.64-1.44],0.8379099320904084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,8011,80,0.84 [0.50-1.43],0.5274868586099655
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,8023,82,1.11 [0.86-1.42],0.4314073198073791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,7871,79,0.71 [0.33-1.56],0.3961187031290627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,9173,88,0.97 [0.73-1.28],0.8276949187444769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],9014,83,0.96 [0.64-1.45],0.8586380655969991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",9182,88,1.00 [0.60-1.67],0.985597295363538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,8052,80,0.73 [0.44-1.20],0.2160834585938464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,8035,82,1.34 [0.92-1.97],0.1304208246709103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,8972,86,1.06 [0.63-1.80],0.8228372678153487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,9206,88,1.05 [0.79-1.40],0.7333730787655433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,9157,88,0.73 [0.43-1.23],0.2353706944508099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,9157,88,1.00 [0.61-1.63],0.9902547050820184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,7841,81,0.68 [0.40-1.17],0.1639889080093662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,8022,82,1.52 [0.63-3.67],0.3541531214236999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,7841,81,1.84 [0.84-4.01],0.1256653463043612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,8035,82,1.13 [0.56-2.29],0.7323426483364828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,8035,82,0.87 [0.58-1.30],0.4973842854828749
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,9214,89,1.02 [0.78-1.34],0.8743920331656359
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,9193,85,1.50 [0.82-2.76],0.1909937727456598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPART,Spartin,7902,78,0.89 [0.67-1.20],0.448159599732679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,8046,81,0.85 [0.40-1.79],0.6630025661615577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,9182,88,1.47 [0.99-2.19],0.0561439760095176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,7902,78,0.36 [0.20-0.63],0.0003462516215118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,9151,89,1.22 [0.93-1.58],0.1446226826995275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,9182,88,1.25 [0.70-2.25],0.4544180664241123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,9252,88,1.32 [0.92-1.89],0.1346869923943884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,7802,75,1.08 [0.63-1.84],0.7729473693683265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,9160,86,1.49 [0.69-3.25],0.3111671923015517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,9220,88,0.88 [0.56-1.37],0.5647038969734108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,8011,80,0.93 [0.79-1.09],0.3675072469753649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,9110,87,0.86 [0.41-1.85],0.7065514725794322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,9190,88,1.55 [0.89-2.73],0.1246841432015023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,9134,87,1.76 [1.04-2.99],0.0366068770457334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,9271,86,1.33 [0.89-1.99],0.1645388019823755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",7830,79,0.53 [0.30-0.96],0.0357083193894062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,7775,79,0.78 [0.50-1.23],0.2870994820741427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,7921,80,1.07 [0.83-1.37],0.6084499865058358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,8042,80,0.96 [0.71-1.29],0.7783567500843137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,9008,86,1.04 [0.84-1.28],0.711238989623476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",7783,80,1.44 [0.83-2.49],0.196110295769148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,8042,80,1.11 [0.64-1.93],0.7082069831574409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,9197,89,0.94 [0.80-1.10],0.4231839196719394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,9137,86,1.03 [0.75-1.41],0.8639265726202968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,9151,89,0.92 [0.73-1.17],0.5017863780530112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,8046,81,0.71 [0.38-1.35],0.3029264203534637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,8948,82,1.39 [1.10-1.76],0.0060942734685055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",7830,79,1.27 [0.75-2.17],0.3751676504574761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,9157,88,1.02 [0.85-1.23],0.8170550710089817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,9224,85,1.13 [0.71-1.80],0.6043971475891794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,7775,79,0.55 [0.24-1.25],0.154368062867146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,8011,80,0.73 [0.47-1.12],0.147777872754494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,7902,78,1.01 [0.69-1.48],0.9550561491115064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",9137,86,0.96 [0.59-1.57],0.8750525360317811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",9282,86,0.81 [0.42-1.58],0.5453255765069283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",7830,79,0.83 [0.48-1.44],0.515739001997697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,8062,80,0.77 [0.36-1.62],0.4878106916065113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,8023,82,1.06 [0.62-1.80],0.8431088829238699
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,9091,87,0.97 [0.72-1.31],0.8318759978459145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,7830,79,0.82 [0.61-1.11],0.1993996485261499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,9137,86,0.97 [0.84-1.11],0.641414059941065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,7775,79,1.02 [0.75-1.41],0.8821909060424664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,9245,88,1.49 [0.99-2.25],0.0553467110975045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,9172,88,1.05 [0.49-2.26],0.8929034490759284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,7783,80,0.91 [0.67-1.24],0.5494582034508286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,9171,86,0.99 [0.74-1.32],0.9282758510709604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,8996,83,1.08 [0.82-1.41],0.5844866813868388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,8948,82,0.97 [0.71-1.34],0.8755415989377683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,9173,88,0.98 [0.78-1.22],0.8559081934954843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",7775,79,1.10 [0.88-1.38],0.3852834493916293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,8972,86,0.90 [0.64-1.27],0.5515102928206921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,7841,81,0.98 [0.57-1.68],0.9372776694800908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,8042,80,0.87 [0.48-1.59],0.6589324250883648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,9137,86,0.98 [0.71-1.36],0.9161295166520932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,7830,79,0.52 [0.26-1.06],0.0707934985032929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,8972,86,0.92 [0.68-1.24],0.5728780482434916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,7830,79,0.99 [0.64-1.53],0.9594416299303036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,9151,89,0.98 [0.67-1.45],0.9359226076637588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,8035,82,0.96 [0.73-1.27],0.7852206002716324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,8972,86,1.19 [0.79-1.78],0.40162666515403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,8011,80,0.85 [0.49-1.49],0.5688338698121793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,8972,86,1.02 [0.80-1.29],0.8980147027033171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,9245,88,0.93 [0.80-1.07],0.3006216352476663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,9151,89,0.83 [0.57-1.23],0.3586318588820152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,7830,79,1.07 [0.80-1.43],0.6538901433429158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,9245,88,1.19 [0.82-1.72],0.3720431310206646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",8035,82,0.91 [0.64-1.30],0.6201107365707559
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,8996,83,1.03 [0.69-1.54],0.8846246356136912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,9182,88,1.31 [0.71-2.42],0.3875445877053648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,8023,82,1.16 [0.73-1.85],0.5319456017962519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,7854,78,1.45 [0.76-2.76],0.2603162941556289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,7841,81,0.77 [0.53-1.14],0.1913111696640443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,8011,80,0.77 [0.39-1.49],0.4324301347891535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,7902,78,0.91 [0.61-1.36],0.6447537359868738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,7783,80,0.97 [0.67-1.40],0.8662660090415417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,8042,80,1.26 [0.81-1.95],0.3041647856368012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,8046,81,1.08 [0.81-1.43],0.599456326132297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,7921,80,0.90 [0.73-1.10],0.3028170088897118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,9137,86,1.02 [0.86-1.20],0.8425962653465953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,8168,73,0.92 [0.44-1.91],0.8179934111884933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,8023,82,0.70 [0.40-1.23],0.213024068338205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,9137,86,1.04 [0.61-1.76],0.8808161665379163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,7775,79,1.07 [0.76-1.50],0.6948121931776906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,8020,80,0.92 [0.56-1.50],0.7278926885944513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,9008,86,0.97 [0.73-1.29],0.8567961461055135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,7921,80,1.20 [0.91-1.57],0.1897298942048464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,8948,82,0.95 [0.74-1.22],0.6992781017666272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",7841,81,0.91 [0.67-1.22],0.5146560098061872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",8023,82,1.02 [0.58-1.80],0.933856290398187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,8042,80,0.80 [0.56-1.15],0.2286406337219604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,8948,82,0.97 [0.63-1.48],0.8789307648332324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,9137,86,0.89 [0.72-1.10],0.2811860645967123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,9151,89,0.88 [0.69-1.13],0.3095603459552234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,7902,78,0.95 [0.74-1.23],0.7059010348161892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,9110,87,0.95 [0.79-1.15],0.5925816786586394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,9110,87,0.94 [0.74-1.19],0.5962132305338548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,8972,86,0.97 [0.78-1.22],0.8140270114226642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,7841,81,1.26 [0.89-1.78],0.1901214579437534
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,9097,86,1.01 [0.83-1.23],0.9227335945337208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,8996,83,0.75 [0.54-1.04],0.0890081637857269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,7880,79,0.89 [0.47-1.69],0.7156520763854699
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,9271,86,0.89 [0.47-1.68],0.7224269229349864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,8046,81,1.37 [0.77-2.44],0.2910097814406532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,7921,80,0.96 [0.65-1.43],0.8514982480262882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,8046,81,1.36 [0.65-2.84],0.4112504810170353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,8948,82,0.92 [0.80-1.06],0.2548599928306045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",7841,81,0.91 [0.51-1.64],0.7601936125090254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,8023,82,0.87 [0.62-1.23],0.4448650462467963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,8948,82,0.87 [0.69-1.12],0.2809100213709848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,7802,75,1.20 [0.75-1.93],0.4459745258505855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,9214,89,1.71 [0.72-4.04],0.2232014821419389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,7830,79,1.10 [0.54-2.24],0.7863511549050688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,7901,80,1.11 [0.92-1.33],0.2776649191892679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,7841,81,0.70 [0.40-1.22],0.2049508265616253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,7921,80,0.72 [0.38-1.37],0.3216793253099644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,8065,80,0.56 [0.21-1.52],0.2575449933253352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,7783,80,1.00 [0.69-1.44],0.9969257256829224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,9139,88,1.15 [0.93-1.43],0.2084682375041217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,9202,88,1.29 [0.94-1.77],0.1123007200360827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,9174,85,1.40 [0.99-1.99],0.0564982615740859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,9168,85,1.04 [0.54-1.99],0.9141988919835728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,9192,89,0.78 [0.45-1.37],0.3879538283475506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,9223,85,0.98 [0.58-1.64],0.9258390074854338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,8023,82,1.06 [0.89-1.25],0.5218605526644858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,9151,89,1.17 [0.80-1.71],0.4268423231580323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,9253,87,1.03 [0.62-1.70],0.9229277242892407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,8023,82,0.99 [0.66-1.48],0.9645046788098584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,9130,85,0.61 [0.30-1.26],0.1823304947288458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,7830,79,0.42 [0.14-1.24],0.1145673539033566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,9214,89,1.50 [0.89-2.54],0.1290489345927598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,9282,86,1.15 [0.64-2.07],0.6383897808683092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,9164,88,0.91 [0.71-1.16],0.4386904143068428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,8052,80,1.81 [0.85-3.89],0.1263048877498815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,7760,79,0.91 [0.69-1.18],0.4683477339868231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,9173,88,1.85 [0.97-3.52],0.0608717796945651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,9182,88,1.05 [0.62-1.78],0.8495245919798446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,9186,85,1.11 [0.72-1.70],0.6383639841074507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,9120,88,1.15 [0.62-2.13],0.65770956997724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,8996,83,1.20 [0.73-1.97],0.481468759832076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,7802,75,0.95 [0.77-1.17],0.6202473161040672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,7768,79,0.69 [0.34-1.36],0.2816926361123331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,8012,82,0.99 [0.78-1.27],0.9499663133885344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,9245,88,1.73 [0.92-3.28],0.0907198822252344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,8895,82,1.05 [0.89-1.24],0.5556464761922448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,9282,86,1.31 [0.79-2.18],0.3014871955905834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",8929,82,1.08 [0.71-1.63],0.7235141461256285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,7921,80,1.26 [0.74-2.13],0.3929437711444508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,9224,85,1.11 [0.72-1.72],0.6262219697670286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,8046,81,0.80 [0.46-1.39],0.4286109933376565
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,8042,80,1.01 [0.79-1.30],0.9119597543467072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,9096,85,1.32 [0.68-2.58],0.4143431626743854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,8046,81,0.96 [0.41-2.23],0.920384069114345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,9220,88,0.93 [0.81-1.08],0.3308332658234657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,9182,88,1.06 [0.67-1.67],0.8057767450005051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,9143,88,0.91 [0.39-2.15],0.8344444332261093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,9214,89,0.94 [0.75-1.18],0.59964771472675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,7783,80,0.82 [0.47-1.44],0.4919094307210283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",7921,80,0.86 [0.51-1.46],0.5790037502061451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,7830,79,1.17 [0.53-2.57],0.6912581809748188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,7921,80,0.70 [0.28-1.78],0.4574044681126097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,9266,87,1.06 [0.77-1.46],0.7072731613827087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,7830,79,0.94 [0.44-2.01],0.8678477077511888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,7841,81,0.88 [0.58-1.34],0.5513448919674644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,7921,80,1.31 [0.95-1.80],0.0970815372547086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,7802,75,0.57 [0.27-1.19],0.1359548647289024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,7802,75,0.87 [0.56-1.35],0.5401153908061282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,8011,80,0.92 [0.75-1.14],0.4381428566743967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,8023,82,1.03 [0.76-1.38],0.8713832296313906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,7871,79,1.02 [0.73-1.43],0.9113199774369888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,8035,82,1.26 [0.85-1.89],0.2505981748220591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,7775,79,1.44 [0.93-2.21],0.1020910571373887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,7783,80,0.99 [0.75-1.31],0.970453538461948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,8029,80,0.72 [0.41-1.26],0.2460395893955487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,9137,86,0.97 [0.79-1.20],0.8005213264708164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,9069,86,1.32 [0.79-2.19],0.2836264101709599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,9182,88,0.94 [0.72-1.22],0.6226757401593068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,9224,85,1.29 [0.87-1.90],0.1996445456504709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,8975,83,1.21 [0.81-1.79],0.3521134608237265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,8011,80,0.89 [0.55-1.45],0.6501272103323523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,9008,86,1.11 [0.67-1.82],0.6860873806508577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,7902,78,0.90 [0.63-1.29],0.5691036024326583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,9110,87,1.16 [0.65-2.07],0.6196236593089472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,9110,87,1.24 [0.90-1.71],0.1889371428780713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,9198,85,1.07 [0.73-1.57],0.7325426532517183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,9266,87,1.27 [0.79-2.03],0.3225843670711463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,9173,88,0.96 [0.49-1.87],0.892895312389758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,9214,89,1.83 [1.11-3.00],0.0170485273808765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,9190,88,0.66 [0.36-1.22],0.1888700547605411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,9008,86,0.91 [0.56-1.46],0.6848632023164658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,9190,88,1.14 [0.61-2.12],0.6827350724528558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,7902,78,0.62 [0.37-1.06],0.0808312297504207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,9252,88,1.42 [0.80-2.51],0.2325804529718791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,9182,88,1.38 [0.74-2.56],0.312521907753912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,9182,88,1.20 [0.79-1.83],0.3995661289524906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,9245,88,2.34 [1.21-4.52],0.0114642367531976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,9253,87,1.57 [1.00-2.46],0.051698512165454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,9110,87,1.18 [0.86-1.63],0.3098259486245611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,9245,88,1.29 [0.88-1.89],0.1988648307222271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,9110,87,1.51 [0.98-2.33],0.0595982975937207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,9266,87,0.74 [0.35-1.56],0.4251257980369339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,9151,89,1.06 [0.78-1.45],0.7110059692355135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,9266,87,0.86 [0.44-1.68],0.6617600180930141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,9220,88,0.83 [0.40-1.71],0.6200913216634848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,9273,86,0.97 [0.48-1.96],0.9372696918548132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,9110,87,1.11 [0.80-1.54],0.536148925823846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,8062,80,0.86 [0.47-1.57],0.6171092449334507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,8042,80,0.89 [0.69-1.14],0.350566910791222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,8062,80,0.74 [0.45-1.20],0.2175773213372246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",8996,83,1.09 [0.85-1.39],0.4882824601309334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,7921,80,0.60 [0.31-1.15],0.1234253956136905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,9110,87,1.55 [1.00-2.38],0.0475677344884207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,9182,88,1.35 [0.64-2.87],0.4307207911224958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,8046,81,1.00 [0.76-1.31],0.9835374621742708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,8011,80,0.91 [0.73-1.12],0.3638610144119224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",7775,79,0.91 [0.58-1.44],0.6957168170174239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,7830,79,1.06 [0.81-1.39],0.6601877319566507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,7871,79,1.02 [0.67-1.53],0.9377149487820164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,8972,86,0.80 [0.50-1.27],0.3438847346372478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,7830,79,1.01 [0.79-1.30],0.9167032207372664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,7735,76,1.14 [0.75-1.73],0.5425922773255434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,8996,83,1.03 [0.58-1.82],0.9213342249115142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,7841,81,1.18 [0.64-2.18],0.6048991575613709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,7841,81,0.51 [0.27-0.97],0.039509212611022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,7902,78,1.01 [0.82-1.24],0.9051831956159748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,8046,81,1.17 [0.53-2.58],0.6919793675043198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,7802,75,1.09 [0.65-1.84],0.7456999494074856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,8972,86,0.82 [0.62-1.08],0.1551724866779444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,9110,88,0.86 [0.54-1.35],0.4993918881071217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,7921,80,1.09 [0.86-1.39],0.4801499979258035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,8948,82,1.02 [0.63-1.64],0.9418876694216962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,7802,75,0.99 [0.63-1.56],0.9775533837097292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,7775,79,0.73 [0.48-1.12],0.1548538483432587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,9253,87,0.93 [0.65-1.33],0.6725974725223705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,8035,82,0.43 [0.21-0.88],0.0218773280712183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,7830,79,1.23 [0.57-2.67],0.5935439078267803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,9008,86,1.06 [0.80-1.40],0.7028203547209764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,9151,89,0.88 [0.67-1.15],0.3401348242397628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",7830,79,1.24 [0.71-2.16],0.4557769100587112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,7802,75,0.78 [0.45-1.35],0.3782407026956581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,7921,80,0.99 [0.78-1.27],0.9397502168986452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,8062,80,0.64 [0.49-0.84],0.001312886663056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,9173,88,0.86 [0.60-1.25],0.437510677190247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,8052,80,0.89 [0.59-1.35],0.5892466783767739
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,9182,88,1.36 [0.77-2.42],0.2916780652648721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,9252,88,1.09 [0.80-1.47],0.5911805077782237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,9151,89,0.90 [0.72-1.11],0.3218185549059117
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,7904,80,0.94 [0.67-1.32],0.7257915601047804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,8011,80,0.83 [0.68-1.02],0.0697338773114673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,7775,79,0.56 [0.35-0.90],0.0174327266160071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,7841,81,0.68 [0.50-0.93],0.0161377128705013
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,9151,89,0.87 [0.69-1.08],0.2069040587792593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,8023,82,0.93 [0.73-1.19],0.5593230828767568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,7802,75,0.57 [0.33-1.00],0.0511380764705844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,7830,79,0.72 [0.48-1.09],0.1169603129132018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,8035,82,0.94 [0.68-1.30],0.7238539431480937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,9173,88,1.13 [0.91-1.40],0.2592141705688794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,8996,83,0.95 [0.68-1.32],0.7504871256728672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,7802,75,1.16 [0.67-2.01],0.6069483862508747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,8996,83,1.24 [0.65-2.34],0.51288096123001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,7802,75,1.01 [0.66-1.56],0.9536362529061068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,7783,80,0.94 [0.73-1.22],0.6571025219189235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,8011,80,0.77 [0.62-0.95],0.0132434689500613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,7830,79,0.87 [0.50-1.50],0.6162535292910416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,8926,82,1.03 [0.79-1.34],0.8340302048709463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,7841,81,0.66 [0.41-1.06],0.0842857624477116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTN,Titin,7802,75,0.95 [0.66-1.36],0.7708194418705754
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,7973,78,0.96 [0.40-2.30],0.9320589405934068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,7783,80,1.08 [0.49-2.34],0.8552233302591294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,8062,80,0.91 [0.70-1.18],0.4779088938778298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,7921,80,1.07 [0.82-1.38],0.6293783716189155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,9110,87,1.00 [0.80-1.24],0.9655815645114092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,7921,79,0.96 [0.59-1.54],0.8553703705265433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,9214,89,1.66 [0.86-3.22],0.1296574901155789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,9245,88,1.04 [0.79-1.38],0.77444153695418
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,8042,80,0.95 [0.63-1.44],0.8175353090042328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,7768,80,0.87 [0.67-1.13],0.2955441753918086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",9182,88,0.89 [0.58-1.35],0.5755639102392253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,9106,88,0.93 [0.70-1.24],0.6253240920870631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,9173,88,1.34 [0.68-2.62],0.3979560102434007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",7830,79,1.12 [0.79-1.57],0.5295563809115489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,9137,86,0.72 [0.42-1.24],0.2365568781263305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,8023,82,1.10 [0.55-2.22],0.7874005559064678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,8046,81,0.84 [0.59-1.21],0.3592420661976905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,7830,79,0.79 [0.52-1.21],0.2801544788843731
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,7802,75,1.40 [1.02-1.92],0.0355032252735397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,7902,78,0.89 [0.64-1.24],0.4976104659674498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,8011,80,0.96 [0.82-1.13],0.6452323788504399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,7802,75,1.13 [0.93-1.38],0.2074355389292438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,7802,75,0.80 [0.39-1.62],0.5300709976905333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,9110,87,1.46 [0.91-2.36],0.1186283948668052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,9259,85,1.12 [0.78-1.60],0.5399437501318358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,7830,79,1.44 [0.63-3.28],0.3872673293731845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,7775,79,0.94 [0.63-1.38],0.7361814342654012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,8023,82,0.91 [0.48-1.71],0.7594728445847871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,8046,81,1.14 [0.91-1.44],0.254191377774579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,7783,80,0.93 [0.60-1.43],0.7369007895763884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,7907,80,0.96 [0.64-1.45],0.8617366541213609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,7902,78,1.03 [0.76-1.41],0.842275893116966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,7841,81,0.88 [0.63-1.22],0.4363372717964544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,9137,86,0.89 [0.72-1.09],0.255346202579827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,8023,82,0.86 [0.63-1.16],0.3169952553396766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,8042,80,1.11 [0.63-1.95],0.7161358880442266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,7802,75,0.85 [0.63-1.15],0.2896395552055453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,8996,83,1.02 [0.83-1.25],0.882738613011165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,8972,86,1.05 [0.74-1.50],0.7657706140085314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,8996,83,1.03 [0.74-1.44],0.8514261930554093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,7830,79,0.88 [0.69-1.13],0.3255853276251219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,9151,89,1.02 [0.81-1.29],0.8466592243985015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,9037,83,1.65 [0.81-3.36],0.1703875258890317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,8052,80,0.96 [0.71-1.30],0.8039405634312058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,9137,86,0.50 [0.19-1.35],0.1728596426224024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,7783,80,1.00 [0.81-1.25],0.9711230352531144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,9205,85,1.31 [0.65-2.66],0.4548216789000815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,9245,88,1.25 [0.68-2.32],0.4745834088635223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,7775,79,1.13 [0.89-1.42],0.3140724807521225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,9238,87,0.99 [0.72-1.36],0.9385503463207115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,7830,79,0.86 [0.40-1.87],0.7084298617680556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,9214,89,0.86 [0.62-1.20],0.3805635411469412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,9247,87,1.30 [0.75-2.28],0.3513502311556458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,8035,82,1.27 [0.65-2.48],0.4893855723517242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,8996,83,0.81 [0.71-0.93],0.0020677085503031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,7871,79,1.07 [0.46-2.51],0.8701074049494805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,8046,81,1.21 [0.68-2.15],0.5129158316178316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,9137,86,1.00 [0.76-1.33],0.973098118961933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,8052,80,0.88 [0.66-1.17],0.3852353929948899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,9137,86,1.30 [0.84-2.02],0.2371909619078832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,7921,80,0.87 [0.62-1.22],0.4195312258473291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,9137,86,0.91 [0.72-1.17],0.470305773798973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,8023,82,0.94 [0.75-1.18],0.6029615348002324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,9137,86,0.92 [0.72-1.18],0.5182566637506961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,8023,82,1.52 [0.93-2.49],0.0968446005590616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,7802,75,1.69 [0.94-3.03],0.077464406130732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,8023,82,1.29 [0.95-1.76],0.1083917219345826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,9172,88,1.27 [0.80-2.01],0.3038721994502221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,9156,88,1.00 [0.73-1.36],0.9909875128802323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,8042,80,1.55 [0.95-2.53],0.0825380315835889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,8948,82,1.00 [0.67-1.49],0.9985465021194694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,7921,80,0.98 [0.59-1.61],0.923407153855574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,8996,83,1.02 [0.73-1.42],0.906828482831183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,9245,88,0.93 [0.71-1.21],0.5827094626022218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,8972,86,2.30 [1.38-3.83],0.0013849304412889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,7902,78,0.77 [0.52-1.15],0.2089059769576143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,9234,88,1.45 [0.93-2.26],0.102270356579842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,7775,79,1.16 [0.93-1.44],0.2010213675073591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,9077,87,1.71 [1.05-2.77],0.0305319690274021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,8035,82,0.55 [0.28-1.07],0.0763856347974818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,9282,86,1.01 [0.78-1.31],0.9264827205365256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",9182,88,1.07 [0.65-1.76],0.7873658776504819
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,9008,86,0.94 [0.71-1.25],0.6628698872046881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,8996,83,0.98 [0.80-1.22],0.8853941904688262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,8948,82,1.02 [0.81-1.29],0.8547141830791817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,8042,80,0.95 [0.71-1.27],0.7399070477844382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,7830,79,0.92 [0.63-1.34],0.6701727597250093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,8023,82,1.00 [0.55-1.83],0.993690548520683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,7849,81,0.74 [0.45-1.22],0.242399210782937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,9243,88,0.95 [0.71-1.28],0.748760810649387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,8728,83,2.22 [1.50-3.28],6.567829463637424e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",9084,87,1.12 [0.71-1.78],0.6194155601535412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",9190,88,1.51 [0.89-2.56],0.1251134922086216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,9252,88,0.85 [0.49-1.46],0.550122182927413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,9008,86,0.53 [0.25-1.09],0.0823125171698926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,9110,87,0.90 [0.63-1.29],0.5826269505080852
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,9252,88,1.16 [0.85-1.56],0.3487001795340688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,9240,86,1.01 [0.54-1.89],0.976216703886206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,7830,79,0.78 [0.52-1.16],0.2210046581013289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,9214,89,0.84 [0.68-1.04],0.1036546027656662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,8948,82,0.63 [0.36-1.13],0.1197069241849973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,8042,80,1.43 [0.67-3.06],0.357619459594224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",8011,80,1.00 [0.86-1.16],0.9787209333354108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,9137,86,0.92 [0.78-1.09],0.3527700405170123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,8023,82,0.85 [0.43-1.67],0.6417823436197265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,7802,75,0.98 [0.69-1.39],0.9052321038938904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,9008,86,1.03 [0.82-1.29],0.797342616815085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,7902,78,0.95 [0.70-1.29],0.7459557788216507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,7830,79,1.20 [0.59-2.45],0.6201992314876402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,7830,79,0.83 [0.45-1.52],0.542094755667443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,8972,86,0.90 [0.68-1.19],0.4486091190136302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,8996,83,1.13 [0.74-1.73],0.5721696006319539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,7802,75,0.72 [0.46-1.13],0.1497316848975456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,8011,80,1.01 [0.79-1.28],0.943082040259014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,8042,80,0.95 [0.47-1.92],0.882446666247114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,7830,79,0.78 [0.40-1.50],0.4546044329291823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,7921,80,0.97 [0.68-1.38],0.8536214128150748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,8023,82,1.00 [0.76-1.31],0.9905060282631244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,8011,80,1.00 [0.74-1.37],0.9752567141531192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,8023,82,1.08 [0.74-1.57],0.6967410551492549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,7871,79,1.02 [0.94-1.11],0.6627195003234033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,7775,79,1.13 [0.64-2.00],0.6779552890585735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,7783,80,1.07 [0.88-1.31],0.4830174932705727
